{\rtf\ansi\deff0{\fonttbl{\f0 Segoe UI;}{\f1 Century;}{\f2 Symbol;}{\f3 Tahoma;}

}{\colortbl\red0\green0\blue0;\red35\green31\blue32;\red178\green13\blue53;\red2
55\green255\blue255;\red96\green96\blue96;\red128\green128\blue255;}\paperw11338
\paperh15874\margl0\margr0\margt0\margb0\sectd\sbknone\sected\cols1\colno1\colw1
1320\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plai
n\sl-200\par\pard\plain\sl-284\par\pard\plain\li999\sl-173\f0\fs14\cf1\b\i0\ul0\
strike0 CARDIOVASCULAR\par\pard\plain\li999\sl-180\f0\fs14\cf1\b\i0\ul0\strike0
PREVENTION\par\pard\plain\sl-200\par\pard\plain\sl-224\par\pard\plain\li802\sl-3
47\f0\fs30\cf1\b\i0\ul0\strike0 Use\f0\fs30\cf1\b\i0\ul0\strike0 of\f0\fs30\cf1
\b\i0\ul0\strike0 Aspirin\f0\fs30\cf1\b\i0\ul0\strike0 in\f0\fs30\cf1\b\i0\ul0
\strike0 the\f0\fs30\cf1\b\i0\ul0\strike0 Public\f0\fs30\cf1\b\i0\ul0\strike0
Primary\f0\fs30\cf1\b\i0\ul0\strike0 Care\f0\fs30\cf1\b\i0\ul0\strike0 Level.
\f0\fs30\cf1\b\i0\ul0\strike0 Experience\f0\fs30\cf1\b\i0\ul0\strike0 of\f0\fs
30\cf1\b\i0\ul0\strike0 the\par\pard\plain\li802\sl-360\f0\fs30\cf1\b\i0\ul0\st
rike0 Remediar\f0\fs30\cf1\b\i0\ul0\strike0 Program,\f0\fs30\cf1\b\i0\ul0\strik
e0 Argentina.\par\pard\plain\sl-250\par\pard\plain\li822\sl-185\f0\fs16\cf1\b0\
i0\ul0\strike0 RICARDO\f0\fs16\cf1\b0\i0\ul0\strike0 G.\f0\fs16\cf1\b0\i0\ul0\s
trike0 BERNZTEIN\f0\fs10\cf1\b0\i0\ul0\strike0 1\f0\fs16\cf1\b0\i0\ul0\strike0
,\f0\fs16\cf1\b0\i0\ul0\strike0 IGNACIO\f0\fs16\cf1\b0\i0\ul0\strike0 DRAKE\f0
\fs10\cf1\b0\i0\ul0\strike0 1\par\sect\sected\sbknone\cols2\colno1\colw3250\cols
r10\colno2\colw8060\pard\plain\sl-200\par\pard\plain\sl-246\par\pard\plain\li822
\sl-169\f1\fs14\cf1\b0\i\ul0\strike0 Received:\f1\fs14\cf1\b0\i0\ul0\strike0 06/
29/2009\par\pard\plain\li822\sl-167\f1\fs14\cf1\b0\i\ul0\strike0 Accepted:\f1\fs
14\cf1\b0\i0\ul0\strike0 03/11/2010\par\pard\plain\li822\sl-280\f1\fs14\cf2\b0\i
\ul0\strike0 Address\f1\fs14\cf2\b0\i\ul0\strike0 for\f1\fs14\cf2\b0\i\ul0\strik
e0 reprints:\par\pard\plain\li822\sl-167\f1\fs14\cf1\b0\i0\ul0\strike0 Dr.\f1\fs
14\cf1\b0\i0\ul0\strike0 Ricardo\f1\fs14\cf1\b0\i0\ul0\strike0 Bernztein\par\par
d\plain\li822\sl-167\f1\fs14\cf1\b0\i0\ul0\strike0 Subsecretar\u237?a\f1\fs14\cf
1\b0\i0\ul0\strike0 de\f1\fs14\cf1\b0\i0\ul0\strike0 Salud\par\pard\plain\li822\
sl-168\f1\fs14\cf1\b0\i0\ul0\strike0 Comunitaria\par\pard\plain\li822\sl-167\f1\
fs14\cf1\b0\i0\ul0\strike0 Ministerio\f1\fs14\cf1\b0\i0\ul0\strike0 de\f1\fs14\c
f1\b0\i0\ul0\strike0 Salud\f1\fs14\cf1\b0\i0\ul0\strike0 de\f1\fs14\cf1\b0\i0\ul
0\strike0 la\f1\fs14\cf1\b0\i0\ul0\strike0 Naci\u243?n\par\pard\plain\li822\sl-1
68\f1\fs14\cf1\b0\i0\ul0\strike0 Av.\f1\fs14\cf1\b0\i0\ul0\strike0 9\f1\fs14\cf1
\b0\i0\ul0\strike0 de\f1\fs14\cf1\b0\i0\ul0\strike0 Julio\f1\fs14\cf1\b0\i0\ul0\
strike0 1925\f1\fs14\cf1\b0\i0\ul0\strike0 -\f1\fs14\cf1\b0\i0\ul0\strike0 Piso\
f1\fs14\cf1\b0\i0\ul0\strike0 11\par\pard\plain\li822\sl-167\f1\fs14\cf1\b0\i0\u
l0\strike0 (C1073ABA)\f1\fs14\cf1\b0\i0\ul0\strike0 Ciudad\f1\fs14\cf1\b0\i0\ul0
\strike0 Aut\u243?noma\f1\fs14\cf1\b0\i0\ul0\strike0 de\par\pard\plain\li822\sl167\f1\fs14\cf1\b0\i0\ul0\strike0 Buenos\f1\fs14\cf1\b0\i0\ul0\strike0 Aires\par
\pard\plain\li822\sl-168\f1\fs14\cf1\b0\i0\ul0\strike0 Phone\f1\fs14\cf1\b0\i0\u
l0\strike0 011\f1\fs14\cf1\b0\i0\ul0\strike0 4379-9235\par\pard\plain\li822\sl-1
67\f1\fs14\cf1\b0\i0\ul0\strike0 e-mail:\f1\fs14\cf1\b0\i0\ul0\strike0 rbernz@in
tramed.net\par\pard\plain\li822\sl-167\f1\fs14\cf1\b0\i0\ul0\strike0 rbernztein@
msal.gov.ar\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\pa
r\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\s
l-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard
\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\
par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain
\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pa
rd\plain\sl-224\par\pard\plain\li2144\sl-198\f0\fs16\cf2\b\i0\ul0\strike0 Key\f0
\fs16\cf2\b\i0\ul0\strike0 words\f0\fs16\cf2\b0\i0\ul0\strike0 >\par\pard\colu
mn\plain\sl-200\par\pard\plain\sl-242\par\pard\plain\li0\sl-188\f0\fs16\cf2\b0\i
0\ul0\strike0 SUMMARY\par\pard\plain\li0\sl-353\f0\fs16\cf2\b\i0\ul0\strike0 Bac
kground\par\pard\plain\li0\sl-206\f1\fs16\cf1\b0\i0\ul0\strike0 Cardiovascular\f
1\fs16\cf1\b0\i0\ul0\strike0 diseases\f1\fs16\cf1\b0\i0\ul0\strike0 cause\f1\fs1
6\cf1\b0\i0\ul0\strike0 32%\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\u
l0\strike0 deaths\f1\fs16\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strike0
Argentina.\f1\fs16\cf1\b0\i0\ul0\strike0 Aspirin\f1\fs16\cf1\b0\i0\ul0\strike0
produces\f1\fs16\cf1\b0\i0\ul0\strike0 a\f1\fs16\cf1\b0\i0\ul0\strike0 12%\par\p

ard\plain\li0\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 reduction\f1\fs16\cf1\b0\i0\u
l0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 in
cidence\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 events\f1
\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 is\f1\fs16\cf1\b0\
i0\ul0\strike0 indicated\f1\fs16\cf1\b0\i0\ul0\strike0 when\f1\fs16\cf1\b0\i0\ul
0\strike0 cardiovascular\f1\fs16\cf1\b0\i0\ul0\strike0 risk\f1\fs16\cf1\b0\i0\ul
0\strike0 at\f1\fs16\cf1\b0\i0\ul0\strike0 10\f1\fs16\cf1\b0\i0\ul0\strike0 year
s\f1\fs16\cf1\b0\i0\ul0\strike0 is\par\pard\plain\li0\sl-203\f1\fs16\cf1\b0\i0\u
l0\strike0 above\f1\fs16\cf1\b0\i0\ul0\strike0 10%.\f1\fs16\cf1\b0\i0\ul0\strike
0 The\f1\fs16\cf1\b0\i0\ul0\strike0 Remediar\f1\fs16\cf1\b0\i0\ul0\strike0 Progr
am\f1\fs16\cf1\b0\i0\ul0\strike0 provides\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\
f1\fs16\cf1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 patients\f1\fs16\
cf1\b0\i0\ul0\strike0 without\f1\fs16\cf1\b0\i0\ul0\strike0 medical\f1\fs16\cf1\
b0\i0\ul0\strike0 coverage\f1\fs16\cf1\b0\i0\ul0\strike0 in\par\pard\plain\li0\s
l-204\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 public\f1\
fs16\cf1\b0\i0\ul0\strike0 primary\f1\fs16\cf1\b0\i0\ul0\strike0 care\f1\fs16\cf
1\b0\i0\ul0\strike0 level.\par\pard\plain\li0\sl-337\f0\fs16\cf2\b\i0\ul0\strike
0 Objective\par\pard\plain\li0\sl-206\f1\fs16\cf1\b0\i0\ul0\strike0 To\f1\fs16\c
f1\b0\i0\ul0\strike0 analyze\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0
\ul0\strike0 use\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0
aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 estimate
\f1\fs16\cf1\b0\i0\ul0\strike0 its\f1\fs16\cf1\b0\i0\ul0\strike0 indication.\par
\pard\plain\li0\sl-337\f0\fs16\cf2\b\i0\ul0\strike0 Material\f0\fs16\cf2\b\i0\ul
0\strike0 and\f0\fs16\cf2\b\i0\ul0\strike0 Methods\par\pard\plain\li0\sl-206\f
1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b0\i0\ul0\strike0 present\f1\fs16\c
f1\b0\i0\ul0\strike0 study\f1\fs16\cf1\b0\i0\ul0\strike0 has\f1\fs16\cf1\b0\i0\u
l0\strike0 three\f1\fs16\cf1\b0\i0\ul0\strike0 designs:\f1\fs16\cf1\b0\i0\ul0\st
rike0 1.\f1\fs16\cf1\b0\i0\ul0\strike0 Ecological\f1\fs16\cf1\b0\i0\ul0\strike0
study\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\strike0 cross\f1\
fs16\cf1\b0\i0\ul0\strike0 comparisons\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\
cf1\b0\i0\ul0\strike0 aspirin\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\ul0\st
rike0 prescriptions,\f1\fs16\cf1\b0\i0\ul0\strike0 diagnoses\f1\fs16\cf1\b0\i0\u
l0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 beneficiaries,\f1\fs16\cf1\b0\i0\ul
0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 province,\f1\fs16\cf1\b0\i0\ul0\strik
e0 of\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 prescripti
ons\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\c
f1\b0\i0\ul0\strike0 Remediar\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\ul0\st
rike0 Program.\f1\fs16\cf1\b0\i0\ul0\strike0 Sources:\f1\fs16\cf1\b0\i0\ul0\stri
ke0 prescriptions\f1\fs16\cf1\b0\i0\ul0\strike0 from\f1\fs16\cf1\b0\i0\ul0\strik
e0 6000\f1\fs16\cf1\b0\i0\ul0\strike0 health\f1\fs16\cf1\b0\i0\ul0\strike0 care\
f1\fs16\cf1\b0\i0\ul0\strike0 centers\f1\fs16\cf1\b0\i0\ul0\strike0 from\f1\fs16
\cf1\b0\i0\ul0\strike0 March\f1\fs16\cf1\b0\i0\ul0\strike0 2005\f1\fs16\cf1\b0\i
0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 February\par\pard\plain\li0\sl-20
3\f1\fs16\cf1\b0\i0\ul0\strike0 2006.\f1\fs16\cf1\b0\i0\ul0\strike0 2.\f1\fs16\c
f1\b0\i0\ul0\strike0 Evaluation\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\
i0\ul0\strike0 a\f1\fs16\cf1\b0\i0\ul0\strike0 counterfactual\f1\fs16\cf1\b0\i0\
ul0\strike0 approach.\f1\fs16\cf1\b0\i0\ul0\strike0 3.\f1\fs16\cf1\b0\i0\ul0\str
ike0 Estimate\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 med
ication\f1\fs16\cf1\b0\i0\ul0\strike0 costs\f1\fs16\cf1\b0\i0\ul0\strike0 based\
f1\fs16\cf1\b0\i0\ul0\strike0 on\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\ul0
\strike0 results.\par\pard\plain\li0\sl-337\f0\fs16\cf2\b\i0\ul0\strike0 Results
\par\pard\plain\li0\sl-206\f1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b0\i0\u
l0\strike0 Remediar\f1\fs16\cf1\b0\i0\ul0\strike0 Program\f1\fs16\cf1\b0\i0\ul0\
strike0 identified\f1\fs16\cf1\b0\i0\ul0\strike0 708\f1\fs16\cf1\b0\i0\ul0\strik
e0 470\f1\fs16\cf1\b0\i0\ul0\strike0 beneficiaries\f1\fs16\cf1\b0\i0\ul0\strike0
>50\f1\fs16\cf1\b0\i0\ul0\strike0 years\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\f
s16\cf1\b0\i0\ul0\strike0 increased\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\
ul0\strike0 cardiovascular\f1\fs16\cf1\b0\i0\ul0\strike0 risk.\f1\fs16\cf1\b0\i0
\ul0\strike0 Aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 was\f1\fs16\cf1\b0\i0\ul0\str
ike0 prescribed\f1\fs16\cf1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 6

0\f1\fs16\cf1\b0\i0\ul0\strike0 408\f1\fs16\cf1\b0\i0\ul0\strike0 beneficiaries,

\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\strike0 a\f1\fs16\cf1\
b0\i0\ul0\strike0 mean\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\st
rike0 2.0\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 treatments\f1\
fs16\cf1\b0\i0\ul0\strike0 per\f1\fs16\cf1\b0\i0\ul0\strike0 month/year\f1\fs16\
cf1\b0\i0\ul0\strike0 despite\f1\fs16\cf1\b0\i0\ul0\strike0 drug\f1\fs16\cf1\b0\
i0\ul0\strike0 availability.\f1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b0\i0
\ul0\strike0 Program\f1\fs16\cf1\b0\i0\ul0\strike0 provided\f1\fs16\cf1\b0\i0\ul
0\strike0 national\par\pard\plain\li0\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 cover
age\f1\fs16\cf1\b0\i0\ul0\strike0 for\f1\fs16\cf1\b0\i0\ul0\strike0 6.8%\f1\fs16
\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul
0\strike0 target\f1\fs16\cf1\b0\i0\ul0\strike0 population\f1\fs16\cf1\b0\i0\ul0\
strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 882\f1\fs16\cf1\b0\i0\ul0\strike0 205\f
1\fs16\cf1\b0\i0\ul0\strike0 people,\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\
cf1\b0\i0\ul0\strike0 an\f1\fs16\cf1\b0\i0\ul0\strike0 important\f1\fs16\cf1\b0\
i0\ul0\strike0 variability\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\ul0\strik
e0 among\f1\fs16\cf1\b0\i0\ul0\strike0 provinces.\f1\fs16\cf1\b0\i0\ul0\strike0
The\f1\fs16\cf1\b0\i0\ul0\strike0 evaluation\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1
\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 potential\f1\fs16\
cf1\b0\i0\ul0\strike0 impact\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\
ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 prescription\f1\fs16\cf1\b0\i0
\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strike0 three\par\pard\plain\li0\sl-203\f1
\fs16\cf1\b0\i0\ul0\strike0 counterfactual\f1\fs16\cf1\b0\i0\ul0\strike0 scenari
os\f1\fs16\cf1\b0\i0\ul0\strike0 shows\f1\fs16\cf1\b0\i0\ul0\strike0 that\f1\fs1
6\cf1\b0\i0\ul0\strike0 725\f1\fs16\cf1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\u
l0\strike0 21\f1\fs16\cf1\b0\i0\ul0\strike0 173\f1\fs16\cf1\b0\i0\ul0\strike0 ev
ents\f1\fs16\cf1\b0\i0\ul0\strike0 could\f1\fs16\cf1\b0\i0\ul0\strike0 have\f1\f
s16\cf1\b0\i0\ul0\strike0 been\f1\fs16\cf1\b0\i0\ul0\strike0 prevented,\f1\fs16\
cf1\b0\i0\ul0\strike0 and\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\ul0\strike
0 that\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 cost\f1\f
s16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0
\ul0\strike0 Remediar\f1\fs16\cf1\b0\i0\ul0\strike0 Program\f1\fs16\cf1\b0\i0\ul
0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 prevent\f1\fs16\cf1\b0\i0\ul0\strike0
one\f1\fs16\cf1\b0\i0\ul0\strike0 event\f1\fs16\cf1\b0\i0\ul0\strike0 would\f1\
fs16\cf1\b0\i0\ul0\strike0 be\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0
\ul0\strike0 USD\f1\fs16\cf1\b0\i0\ul0\strike0 3111\f1\fs16\cf1\b0\i0\ul0\strike
0 to\f1\fs16\cf1\b0\i0\ul0\strike0 6222\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0
\i0\ul0\strike0 during\f1\fs16\cf1\b0\i0\ul0\strike0 10\f1\fs16\cf1\b0\i0\ul0\st
rike0 years.\par\pard\plain\li0\sl-337\f0\fs16\cf2\b\i0\ul0\strike0 Conclusions\
par\pard\plain\li0\sl-206\f1\fs16\cf1\b0\i0\ul0\strike0 Underprescription\f1\fs1
6\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin,\f1\fs16\cf1\b0
\i0\ul0\strike0 failure\f1\fs16\cf1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\s
trike0 provide\f1\fs16\cf1\b0\i0\ul0\strike0 a\f1\fs16\cf1\b0\i0\ul0\strike0 min
imum\f1\fs16\cf1\b0\i0\ul0\strike0 annual\f1\fs16\cf1\b0\i0\ul0\strike0 number\f
1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 effective\f1\fs16\
cf1\b0\i0\ul0\strike0 treat-\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\ul0\str
ike0 ments\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 acces
s\f1\fs16\cf1\b0\i0\ul0\strike0 issues\f1\fs16\cf1\b0\i0\ul0\strike0 might\f1\fs
16\cf1\b0\i0\ul0\strike0 limit\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\
i0\ul0\strike0 impact\f1\fs16\cf1\b0\i0\ul0\strike0 on\f1\fs16\cf1\b0\i0\ul0\str
ike0 health\f1\fs16\cf1\b0\i0\ul0\strike0 care.\par\pard\plain\li0\sl-340\f1\fs1
6\cf2\b0\i0\ul0\strike0 R\f1\fs12\cf2\b0\i0\ul0\strike0 EV\f1\fs16\cf2\b0\i0\ul0
\strike0 A\f1\fs12\cf2\b0\i0\ul0\strike0 RGENT\f1\fs16\cf2\b0\i0\ul0\strike0 C\f
1\fs12\cf2\b0\i0\ul0\strike0 ARDIOL\f1\fs16\cf2\b0\i0\ul0\strike0 2010;78:330-33
8.\par\pard\plain\sl-200\par\pard\plain\sl-208\par\pard\plain\li92\sl-161\f0\fs1
4\cf1\b0\i0\ul0\strike0 Aspirin\f0\fs14\cf1\b0\i0\ul0\strike0 -\f0\fs14\cf1\b0\
i0\ul0\strike0 Primary\f0\fs14\cf1\b0\i0\ul0\strike0 Health\f0\fs14\cf1\b0\i0\
ul0\strike0 Care\f0\fs14\cf1\b0\i0\ul0\strike0 Level-\f0\fs14\cf1\b0\i0\ul0\st
rike0 Impacts\f0\fs14\cf1\b0\i0\ul0\strike0 on\f0\fs14\cf1\b0\i0\ul0\strike0
Health-\f0\fs14\cf1\b0\i0\ul0\strike0 Public\f0\fs14\cf1\b0\i0\ul0\strike0 Hea

lth\par\sect\sected\sbknone\cols3\colno1\colw3350\colsr10\colno2\colw3570\colsr1
0\colno3\colw4380\pard\plain\sl-269\par\pard\plain\li1864\sl-198\f0\fs16\cf2\b\i
0\ul0\strike0 Abbreviations\f0\fs16\cf2\b0\i0\ul0\strike0 >\par\pard\column\pla
in\sl-275\par\pard\plain\li0\sl-161\f0\fs14\cf1\b\i0\ul0\strike0 S\f0\fs14\cf1\b
0\i0\ul0\strike0 Stroke\par\pard\plain\li0\sl-220\f0\fs14\cf1\b\i0\ul0\strike0
PHCC\f0\fs14\cf1\b0\i0\ul0\strike0 Primary\f0\fs14\cf1\b0\i0\ul0\strike0 Healt
h\f0\fs14\cf1\b0\i0\ul0\strike0 Care\f0\fs14\cf1\b0\i0\ul0\strike0 Center\par\
pard\plain\li0\sl-220\f0\fs14\cf1\b\i0\ul0\strike0 CVD\f0\fs14\cf1\b0\i0\ul0\str
ike0 Cardiovascular\f0\fs14\cf1\b0\i0\ul0\strike0 disease\par\pard\plain\li0\s
l-220\f0\fs14\cf1\b\i0\ul0\strike0 NSRF\f0\fs14\cf1\b0\i0\ul0\strike0 First\f0\
fs14\cf1\b0\i0\ul0\strike0 National\f0\fs14\cf1\b0\i0\ul0\strike0 Survey\f0\fs
14\cf1\b0\i0\ul0\strike0 of\f0\fs14\cf1\b0\i0\ul0\strike0 Risk\f0\fs14\cf1\b0\
i0\ul0\strike0 Factors\par\pard\plain\li0\sl-220\f0\fs14\cf1\b\i0\ul0\strike0 E
PH-INDEC\f0\fs14\cf1\b0\i\ul0\strike0 Encuesta\f0\fs14\cf1\b0\i\ul0\strike0 Pe
rmanente\f0\fs14\cf1\b0\i\ul0\strike0 de\f0\fs14\cf1\b0\i\ul0\strike0 Hogares\
f0\fs14\cf1\b0\i\ul0\strike0 -\par\pard\plain\li0\sl-160\f0\fs14\cf1\b0\i\ul0\s
trike0 Instituto\f0\fs14\cf1\b0\i\ul0\strike0 Nacional\f0\fs14\cf1\b0\i\ul0\str
ike0 de\f0\fs14\cf1\b0\i\ul0\strike0 Estad\u237?stica\f0\fs14\cf1\b0\i\ul0\str
ike0 y\f0\fs14\cf1\b0\i\ul0\strike0 Censos\par\pard\plain\li0\sl-160\f0\fs14\c
f1\b0\i0\ul0\strike0 (Permanent\f0\fs14\cf1\b0\i0\ul0\strike0 Household\f0\fs14
\cf1\b0\i0\ul0\strike0 Survey\f0\fs14\cf1\b0\i0\ul0\strike0 -\f0\fs14\cf1\b0\i
0\ul0\strike0 National\f0\fs14\cf1\b0\i0\ul0\strike0 Institute\par\pard\plain\
li0\sl-160\f0\fs14\cf1\b0\i0\ul0\strike0 of\f0\fs14\cf1\b0\i0\ul0\strike0 Stati
stics\f0\fs14\cf1\b0\i0\ul0\strike0 and\f0\fs14\cf1\b0\i0\ul0\strike0 Censuses
)\par\pard\column\plain\sl-275\par\pard\plain\li0\sl-161\f0\fs14\cf1\b\i0\ul0\st
rike0 HT\f0\fs14\cf1\b0\i0\ul0\strike0 Hypertension\par\pard\plain\li0\sl-220\f
0\fs14\cf1\b\i0\ul0\strike0 MI\f0\fs14\cf1\b0\i0\ul0\strike0 Myocardial\f0\fs14
\cf1\b0\i0\ul0\strike0 infarction\par\pard\plain\li0\sl-220\f0\fs14\cf1\b\i0\ul
0\strike0 WHO\f0\fs14\cf1\b0\i0\ul0\strike0 World\f0\fs14\cf1\b0\i0\ul0\strike0
Health\f0\fs14\cf1\b0\i0\ul0\strike0 Organization\par\pard\plain\li0\sl-220\f
0\fs14\cf1\b\i0\ul0\strike0 PCL\f0\fs14\cf1\b0\i0\ul0\strike0 Primary\f0\fs14\c
f1\b0\i0\ul0\strike0 care\f0\fs14\cf1\b0\i0\ul0\strike0 level\par\pard\plain\l
i0\sl-220\f0\fs14\cf1\b\i0\ul0\strike0 CVR\f0\fs14\cf1\b0\i0\ul0\strike0 Cardio
vascular\f0\fs14\cf1\b0\i0\ul0\strike0 risk\par\sect\sected\sbknone\cols2\colno
1\colw5690\colsr10\colno2\colw5620\pard\plain\sl-366\par\pard\plain\li822\sl-188
\f0\fs16\cf2\b0\i0\ul0\strike0 BACKGROUND\par\pard\plain\sl-251\par\pard\plain\l
i822\sl-229\f1\fs18\cf1\b0\i0\ul0\strike0 In\f1\fs18\cf1\b0\i0\ul0\strike0 Argen
tina,\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 prevalence
\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 cardiovascular\p
ar\pard\plain\li822\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 disease\f1\fs18\cf1\b0\
i0\ul0\strike0 (CVD)\f1\fs18\cf1\b0\i0\ul0\strike0 \u8211?\f1\fs18\cf1\b0\i0\ul0
\strike0 myocardial\f1\fs18\cf1\b0\i0\ul0\strike0 infarction\f1\fs18\cf1\b0\i0\u
l0\strike0 (MI),\f1\fs18\cf1\b0\i0\ul0\strike0 stroke\par\pard\plain\li822\sl-22
7\f1\fs18\cf1\b0\i0\ul0\strike0 (S),\f1\fs18\cf1\b0\i0\ul0\strike0 peripheral\f1
\fs18\cf1\b0\i0\ul0\strike0 vascular\f1\fs18\cf1\b0\i0\ul0\strike0 disease\f1\fs
18\cf1\b0\i0\ul0\strike0 (PVD)\f1\fs18\cf1\b0\i0\ul0\strike0 \u8211?\f1\fs18\cf1
\b0\i0\ul0\strike0 is\f1\fs18\cf1\b0\i0\ul0\strike0 very\f1\fs18\cf1\b0\i0\ul0\s
trike0 high\par\pard\plain\li822\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs1
8\cf1\b0\i0\ul0\strike0 is\f1\fs18\cf1\b0\i0\ul0\strike0 responsible\f1\fs18\cf1
\b0\i0\ul0\strike0 for\f1\fs18\cf1\b0\i0\ul0\strike0 32%\f1\fs18\cf1\b0\i0\ul0\s
trike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 deaths.\f1\fs18\cf1\b0\i0\ul0\strike0 (1
)\f1\fs18\cf1\b0\i0\ul0\strike0 Cardiovascular\par\pard\plain\li822\sl-227\f1\fs
18\cf1\b0\i0\ul0\strike0 disease\f1\fs18\cf1\b0\i0\ul0\strike0 is\f1\fs18\cf1\b0
\i0\ul0\strike0 more\f1\fs18\cf1\b0\i0\ul0\strike0 frequent\f1\fs18\cf1\b0\i0\ul
0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 older\f1\fs18\cf1\b0\i0\ul0\strike0 p
eople,\f1\fs18\cf1\b0\i0\ul0\strike0 with\f1\fs18\cf1\b0\i0\ul0\strike0 known\pa
r\pard\plain\li822\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 risk\f1\fs18\cf1\b0\i0\u
l0\strike0 factors,\f1\fs18\cf1\b0\i0\ul0\strike0 such\f1\fs18\cf1\b0\i0\ul0\str
ike0 as\f1\fs18\cf1\b0\i0\ul0\strike0 sedentary\f1\fs18\cf1\b0\i0\ul0\strike0 li
fe,\f1\fs18\cf1\b0\i0\ul0\strike0 hypertension,\par\pard\plain\li822\sl-228\f1\f

s18\cf1\b0\i0\ul0\strike0 hypercholesterolemia,\f1\fs18\cf1\b0\i0\ul0\strike0 ob
esity,\f1\fs18\cf1\b0\i0\ul0\strike0 diabetes\f1\fs18\cf1\b0\i0\ul0\strike0 or\f
1\fs18\cf1\b0\i0\ul0\strike0 history\f1\fs18\cf1\b0\i0\ul0\strike0 of\par\pard\p
lain\li817\sl-363\f1\fs14\cf1\b0\i0\ul0\strike0 Remediar\f1\fs14\cf1\b0\i0\ul0\s
trike0 Program,\f1\fs14\cf1\b0\i0\ul0\strike0 Ministry\f1\fs14\cf1\b0\i0\ul0\str
ike0 of\f1\fs14\cf1\b0\i0\ul0\strike0 Health,\f1\fs14\cf1\b0\i0\ul0\strike0 Arge
ntina\par\pard\plain\li817\sl-167\f1\fs10\cf1\b0\i0\ul0\strike0 1\f1\fs14\cf1\b0
\i0\ul0\strike0 Ministry\f1\fs14\cf1\b0\i0\ul0\strike0 of\f1\fs14\cf1\b0\i0\ul0\
strike0 Health,\f1\fs14\cf1\b0\i0\ul0\strike0 Argentina.\par\pard\column\plain\s
l-342\par\pard\plain\li0\sl-229\f1\fs18\cf1\b0\i0\ul0\strike0 smoking\f1\fs18\cf
1\b0\i0\ul0\strike0 habits.\f1\fs18\cf1\b0\i0\ul0\strike0 (2)\f1\fs18\cf1\b0\i0\
ul0\strike0 The\f1\fs18\cf1\b0\i0\ul0\strike0 Framingham\f1\fs18\cf1\b0\i0\ul0\s
trike0 risk\f1\fs18\cf1\b0\i0\ul0\strike0 equation\par\pard\plain\li0\sl-227\f1\
fs18\cf1\b0\i0\ul0\strike0 is\f1\fs18\cf1\b0\i0\ul0\strike0 useful\f1\fs18\cf1\b
0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 evaluate\f1\fs18\cf1\b0\i0\ul0
\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 risk\f1\fs18\cf1\b0\i0\ul0\strike0 of
\f1\fs18\cf1\b0\i0\ul0\strike0 developing\f1\fs18\cf1\b0\i0\ul0\strike0 a\f1\fs1
8\cf1\b0\i0\ul0\strike0 \u8220?hard\u8221?\par\pard\plain\li0\sl-228\f1\fs18\cf1
\b0\i0\ul0\strike0 coronary\f1\fs18\cf1\b0\i0\ul0\strike0 event,\f1\fs18\cf1\b0\
i0\ul0\strike0 such\f1\fs18\cf1\b0\i0\ul0\strike0 as\f1\fs18\cf1\b0\i0\ul0\strik
e0 myocardial\f1\fs18\cf1\b0\i0\ul0\strike0 infarction\f1\fs18\cf1\b0\i0\ul0\str
ike0 or\f1\fs18\cf1\b0\i0\ul0\strike0 death\par\pard\plain\li0\sl-227\f1\fs18\cf
1\b0\i0\ul0\strike0 due\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\s
trike0 coronary\f1\fs18\cf1\b0\i0\ul0\strike0 artery\f1\fs18\cf1\b0\i0\ul0\strik
e0 disease\f1\fs18\cf1\b0\i0\ul0\strike0 \u8211?\f1\fs18\cf1\b0\i0\ul0\strike0 c
ardiovascular\f1\fs18\cf1\b0\i0\ul0\strike0 risk\par\pard\plain\li0\sl-228\f1\fs
18\cf1\b0\i0\ul0\strike0 (CVR).\f1\fs18\cf1\b0\i0\ul0\strike0 (3)\par\pard\plain
\li283\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 Lifelong\f1\fs18\cf1\b0\i0\ul0\strik
e0 low-dose\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strike0
therapy\f1\fs18\cf1\b0\i0\ul0\strike0 might\f1\fs18\cf1\b0\i0\ul0\strike0 be\f1\
fs18\cf1\b0\i0\ul0\strike0 very\par\pard\plain\li0\sl-227\f1\fs18\cf1\b0\i0\ul0\
strike0 effective\f1\fs18\cf1\b0\i0\ul0\strike0 for\f1\fs18\cf1\b0\i0\ul0\strike
0 primary\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 second
ary\f1\fs18\cf1\b0\i0\ul0\strike0 prevention\f1\fs18\cf1\b0\i0\ul0\strike0 of\pa
r\pard\plain\li0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 CVD.\f1\fs18\cf1\b0\i0\ul0
\strike0 A\f1\fs18\cf1\b0\i0\ul0\strike0 meta-analysis\f1\fs18\cf1\b0\i0\ul0\str
ike0 that\f1\fs18\cf1\b0\i0\ul0\strike0 included\f1\fs18\cf1\b0\i0\ul0\strike0 f
ive\f1\fs18\cf1\b0\i0\ul0\strike0 randomized\par\pard\plain\li0\sl-227\f1\fs18\c
f1\b0\i0\ul0\strike0 trials\f1\fs18\cf1\b0\i0\ul0\strike0 (more\f1\fs18\cf1\b0\i
0\ul0\strike0 than\f1\fs18\cf1\b0\i0\ul0\strike0 55,000\f1\fs18\cf1\b0\i0\ul0\st
rike0 patients),\f1\fs18\cf1\b0\i0\ul0\strike0 examined\f1\fs18\cf1\b0\i0\ul0\st
rike0 the
{\shp{\*\shpinst\shpleft3270\shptop10153\shpright10356\shpbottom10445
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz1\shplid1325
{\sp{\sn shapeType}{\sv 0}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn geoRight}{\sv 7086}}
{\sp{\sn geoBottom}{\sv 292}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn pVerticies}{\sv 8;5;(0,292);(7087,292);(7087,0);(0,0);(0,292)}}
{\sp{\sn pSegmentInfo}{\sv 2;12;16384;45824;1;45824;1;45824;1;45824;1;45824;2457
7;32768}}
{\sp{\sn fFillOK}{\sv 1}}
{\sp{\sn fFilled}{\sv 1}}
{\sp{\sn fillColor}{\sv 14606046}}
{\sp{\sn lineWidth}{\sv 12700}}

{\sp{\sn fLine}{\sv 0}}

{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft3270\shptop10620\shpright10356\shpbottom12220
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz2\shplid1325
{\sp{\sn shapeType}{\sv 0}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn geoRight}{\sv 7086}}
{\sp{\sn geoBottom}{\sv 1600}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn pVerticies}{\sv 8;5;(0,1600);(7087,1600);(7087,0);(0,0);(0,1600)}}
{\sp{\sn pSegmentInfo}{\sv 2;12;16384;45824;1;45824;1;45824;1;45824;1;45824;2457
7;32768}}
{\sp{\sn fFillOK}{\sv 1}}
{\sp{\sn fFilled}{\sv 1}}
{\sp{\sn fillColor}{\sv 14606046}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn fLine}{\sv 0}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft822\shptop1055\shpright2948\shpbottom1452
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz3\shplid1325
{\sp{\sn shapeType}{\sv 0}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn geoRight}{\sv 2126}}
{\sp{\sn geoBottom}{\sv 397}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn pVerticies}{\sv 8;5;(0,397);(2126,397);(2126,0);(0,0);(0,397)}}
{\sp{\sn pSegmentInfo}{\sv 2;12;16384;45824;1;45824;1;45824;1;45824;1;45824;2457
7;32768}}
{\sp{\sn fFillOK}{\sv 1}}
{\sp{\sn fFilled}{\sv 1}}
{\sp{\sn fillColor}{\sv 14606046}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn fLine}{\sv 0}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft862\shptop1056\shpright862\shpbottom1452
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz4\shplid2385
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}

{\sp{\sn shapePath}{\sv 4}}

{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 3476658}}
{\sp{\sn lineWidth}{\sv 50800}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft3147\shptop3476\shpright3147\shpbottom9798
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz30\shplid2385
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 3476658}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft6808\shptop10670\shpright6808\shpbottom12113
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz97\shplid2385
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 2105123}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft10346\shptop14683\shpright822\shpbottom14683
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz117\shplid2385
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 3476658}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}

{\sp{\sn fBehindDocument}{\sv 1}}

}}\sect\sectd\sbkpage\pgwsxn11338\pghsxn15874\sected\cols2\colno1\colw5850\colsr
10\colno2\colw5460\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200
\par\pard\plain\sl-200\par\pard\plain\sl-225\par\pard\plain\li992\sl-168\f0\fs14
\cf1\b0\i0\ul0\strike0 ASPIRIN\f0\fs14\cf1\b0\i0\ul0\strike0 IN\f0\fs14\cf1\b0\
i0\ul0\strike0 THE\f0\fs14\cf1\b0\i0\ul0\strike0 REMEDIAR\f0\fs14\cf1\b0\i0\ul
0\strike0 PROGRAM\f1\fs14\cf1\b0\i0\ul0\strike0 /\f0\fs14\cf1\b0\i0\ul0\strike0
Ricardo\f0\fs14\cf1\b0\i0\ul0\strike0 G.\f0\fs14\cf1\b0\i0\ul0\strike0 Bernz
tein\f0\fs14\cf1\b0\i0\ul0\strike0 y\f0\fs14\cf1\b0\i0\ul0\strike0 col.\par\pa
rd\plain\sl-332\par\pard\plain\li992\sl-229\f1\fs18\cf1\b0\i0\ul0\strike0 effect
s\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18
\cf1\b0\i0\ul0\strike0 taken\f1\fs18\cf1\b0\i0\ul0\strike0 every\f1\fs18\cf1\b0\
i0\ul0\strike0 day\f1\fs18\cf1\b0\i0\ul0\strike0 during\f1\fs18\cf1\b0\i0\ul0\st
rike0 4\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 7\f1\fs18
\cf1\b0\i0\ul0\strike0 years,\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\
strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 concluded\f1\fs18\cf1\b0\i0\ul0\strike
0 that\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strike0 reduc
es\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 risk\f1\fs18\
cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 MI\f1\fs18\cf1\b0\i0\ul0\
strike0 and\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 mortality\
f1\fs18\cf1\b0\i0\ul0\strike0 due\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b
0\i0\ul0\strike0 coronary\f1\fs18\cf1\b0\i0\ul0\strike0 artery\f1\fs18\cf1\b0\i0
\ul0\strike0 disease\f1\fs18\cf1\b0\i0\ul0\strike0 by\f1\fs18\cf1\b0\i0\ul0\stri
ke0 28%,\f1\fs18\cf1\b0\i0\ul0\strike0 and\par\pard\plain\li992\sl-228\f1\fs18\c
f1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 risk\f1\fs18\cf1\b0\i0\ul
0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 other\f1\fs18\cf1\b0\i0\ul0\strike0 C
VDs\f1\fs18\cf1\b0\i0\ul0\strike0 by\f1\fs18\cf1\b0\i0\ul0\strike0 15%.\f1\fs18\
cf1\b0\i0\ul0\strike0 (4)\f1\fs18\cf1\b0\i0\ul0\strike0 The\f1\fs18\cf1\b0\i0\ul
0\strike0 effectiveness\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike
0 of\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strike0 for\f1\
fs18\cf1\b0\i0\ul0\strike0 primary\f1\fs18\cf1\b0\i0\ul0\strike0 prevention\f1\f
s18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 CVD\f1\fs18\cf1\b0\i0
\ul0\strike0 far\f1\fs18\cf1\b0\i0\ul0\strike0 exceeds\par\pard\plain\li992\sl-2
28\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 risks\f1\fs18
\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 adverse\f1\fs18\cf1\b0\i
0\ul0\strike0 effects\f1\fs18\cf1\b0\i0\ul0\strike0 when\f1\fs18\cf1\b0\i0\ul0\s
trike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 overall\f1\fs18\cf1\b0\i0\ul0\strike0 r
isk\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\
i0\ul0\strike0 coronary\f1\fs18\cf1\b0\i0\ul0\strike0 artery\f1\fs18\cf1\b0\i0\u
l0\strike0 disease\f1\fs18\cf1\b0\i0\ul0\strike0 at\f1\fs18\cf1\b0\i0\ul0\strike
0 5\f1\fs18\cf1\b0\i0\ul0\strike0 years\f1\fs18\cf1\b0\i0\ul0\strike0 is\f1\fs18
\cf1\b0\i0\ul0\strike0 >\f1\fs18\cf1\b0\i0\ul0\strike0 3%.\f1\fs18\cf1\b0\i0\ul0
\strike0 In\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 patients\f
1\fs18\cf1\b0\i0\ul0\strike0 with\f1\fs18\cf1\b0\i0\ul0\strike0 such\f1\fs18\cf1
\b0\i0\ul0\strike0 CVR\f1\fs18\cf1\b0\i0\ul0\strike0 it\f1\fs18\cf1\b0\i0\ul0\st
rike0 is\f1\fs18\cf1\b0\i0\ul0\strike0 necessary\f1\fs18\cf1\b0\i0\ul0\strike0 t
o\f1\fs18\cf1\b0\i0\ul0\strike0 treat\f1\fs18\cf1\b0\i0\ul0\strike0 1000\par\par
d\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 subjects\f1\fs18\cf1\b0\i0\ul
0\strike0 with\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strik
e0 to\f1\fs18\cf1\b0\i0\ul0\strike0 prevent\f1\fs18\cf1\b0\i0\ul0\strike0 4\f1\f
s18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 12\f1\fs18\cf1\b0\i0\
ul0\strike0 MIs,\f1\fs18\cf1\b0\i0\ul0\strike0 while\par\pard\plain\li992\sl-227
\f1\fs18\cf1\b0\i0\ul0\strike0 0\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0
\i0\ul0\strike0 1\f1\fs18\cf1\b0\i0\ul0\strike0 hemorraghic\f1\fs18\cf1\b0\i0\ul
0\strike0 strokes\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike
0 2\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 4\f1\fs18\cf1
\b0\i0\ul0\strike0 episodes\f1\fs18\cf1\b0\i0\ul0\strike0 of\par\pard\plain\li99
2\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 gastrointestinal\f1\fs18\cf1\b0\i0\ul0\st
rike0 bleeding\f1\fs18\cf1\b0\i0\ul0\strike0 may\f1\fs18\cf1\b0\i0\ul0\strike0 o
ccur\f1\fs18\cf1\b0\i0\ul0\strike0 at\f1\fs18\cf1\b0\i0\ul0\strike0 5\f1\fs18\cf

1\b0\i0\ul0\strike0 years.\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\str
ike0 When\f1\fs18\cf1\b0\i0\ul0\strike0 CVR\f1\fs18\cf1\b0\i0\ul0\strike0 is\f1\
fs18\cf1\b0\i0\ul0\strike0 5%,\f1\fs18\cf1\b0\i0\ul0\strike0 6\f1\fs18\cf1\b0\i0
\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 20\f1\fs18\cf1\b0\i0\ul0\strike0 M
Is\f1\fs18\cf1\b0\i0\ul0\strike0 are\f1\fs18\cf1\b0\i0\ul0\strike0 prevented\f1\
fs18\cf1\b0\i0\ul0\strike0 with\f1\fs18\cf1\b0\i0\ul0\strike0 a\par\pard\plain\l
i992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 similar\f1\fs18\cf1\b0\i0\ul0\strike0
risk\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 adverse\f1\f
s18\cf1\b0\i0\ul0\strike0 effects.\f1\fs18\cf1\b0\i0\ul0\strike0 In\f1\fs18\cf1\
b0\i0\ul0\strike0 2005,\f1\fs18\cf1\b0\i0\ul0\strike0 new\f1\fs18\cf1\b0\i0\ul0\
strike0 evidence\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 provi
ded\f1\fs18\cf1\b0\i0\ul0\strike0 information\f1\fs18\cf1\b0\i0\ul0\strike0 abou
t\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 effects\f1\fs1
8\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\
i0\ul0\strike0 in\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 wome
n,\f1\fs18\cf1\b0\i0\ul0\strike0 (5)\f1\fs18\cf1\b0\i0\ul0\strike0 confirming\f1
\fs18\cf1\b0\i0\ul0\strike0 that\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\c
f1\b0\i0\ul0\strike0 reduces\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0
\ul0\strike0 risk\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 of\f
1\fs18\cf1\b0\i0\ul0\strike0 CVD\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0
\i0\ul0\strike0 adults\f1\fs18\cf1\b0\i0\ul0\strike0 -\f1\fs18\cf1\b0\i0\ul0\str
ike0 MI\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 men\f1\fs
18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 ischemic\f1\fs18\cf1\
b0\i0\ul0\strike0 stroke\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strik
e0 in\f1\fs18\cf1\b0\i0\ul0\strike0 women\f1\fs18\cf1\b0\i0\ul0\strike0 -without
\f1\fs18\cf1\b0\i0\ul0\strike0 previous\f1\fs18\cf1\b0\i0\ul0\strike0 CVD.\f1\fs
18\cf1\b0\i0\ul0\strike0 (6)\f1\fs18\cf1\b0\i0\ul0\strike0 Sixty\f1\fs18\cf1\b0\
i0\ul0\strike0 percent\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0
of\f1\fs18\cf1\b0\i0\ul0\strike0 diabetics\f1\fs18\cf1\b0\i0\ul0\strike0 die\f1
\fs18\cf1\b0\i0\ul0\strike0 due\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\
i0\ul0\strike0 CVD.\f1\fs18\cf1\b0\i0\ul0\strike0 However,\f1\fs18\cf1\b0\i0\ul0
\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 use\f1\fs18\cf1\b0\i0\ul0\strike0 of\
par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0
\i0\ul0\strike0 for\f1\fs18\cf1\b0\i0\ul0\strike0 primary\f1\fs18\cf1\b0\i0\ul0\
strike0 prevention\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike
0 CVD\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 that\f1\fs1
8\cf1\b0\i0\ul0\strike0 population\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0
\ul0\strike0 is\f1\fs18\cf1\b0\i0\ul0\strike0 controversial\f1\fs18\cf1\b0\i0\ul
0\strike0 despite\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike
0 pharmacological\f1\fs18\cf1\b0\i0\ul0\strike0 targets\par\pard\plain\li992\sl227\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\c
f1\b0\i0\ul0\strike0 current\f1\fs18\cf1\b0\i0\ul0\strike0 guidelines.\f1\fs18\c
f1\b0\i0\ul0\strike0 (7)\f1\fs18\cf1\b0\i0\ul0\strike0 A\f1\fs18\cf1\b0\i0\ul0\s
trike0 study\f1\fs18\cf1\b0\i0\ul0\strike0 performed\f1\fs18\cf1\b0\i0\ul0\strik
e0 in\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 Japan\f1\fs18\cf
1\b0\i0\ul0\strike0 reported\f1\fs18\cf1\b0\i0\ul0\strike0 that\f1\fs18\cf1\b0\i
0\ul0\strike0 low-dose\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\u
l0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 patients\f1\fs18\cf1\b0\i0\ul0\strik
e0 with\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 type\f1\fs18\c
f1\b0\i0\ul0\strike0 2\f1\fs18\cf1\b0\i0\ul0\strike0 diabetes\f1\fs18\cf1\b0\i0\
ul0\strike0 did\f1\fs18\cf1\b0\i0\ul0\strike0 not\f1\fs18\cf1\b0\i0\ul0\strike0
produce\f1\fs18\cf1\b0\i0\ul0\strike0 significant\f1\fs18\cf1\b0\i0\ul0\strike0
outcomes,\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 just\f1\fs18
\cf1\b0\i0\ul0\strike0 a\f1\fs18\cf1\b0\i0\ul0\strike0 slight\f1\fs18\cf1\b0\i0\
ul0\strike0 (not\f1\fs18\cf1\b0\i0\ul0\strike0 significant)\f1\fs18\cf1\b0\i0\ul
0\strike0 reduction\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strik
e0 the\f1\fs18\cf1\b0\i0\ul0\strike0 risk\par\pard\plain\li992\sl-227\f1\fs18\cf
1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 coronary\f1\fs18\cf1\b0\i0\
ul0\strike0 artery\f1\fs18\cf1\b0\i0\ul0\strike0 events,\f1\fs18\cf1\b0\i0\ul0\s
trike0 cerebrovascular\f1\fs18\cf1\b0\i0\ul0\strike0 events\par\pard\plain\li992

\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 peripher

al\f1\fs18\cf1\b0\i0\ul0\strike0 events\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18
\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 population,\f1\fs18\cf1
\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 a\par\pard\plain\li992\sl-2
28\f1\fs18\cf1\b0\i0\ul0\strike0 significant\f1\fs18\cf1\b0\i0\ul0\strike0 reduc
tion\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\
cf1\b0\i0\ul0\strike0 incidence\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\
i0\ul0\strike0 fatal\f1\fs18\cf1\b0\i0\ul0\strike0 coronary\par\pard\plain\li992
\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 cerebrov
ascular\f1\fs18\cf1\b0\i0\ul0\strike0 events.\f1\fs18\cf1\b0\i0\ul0\strike0 (8)\
f1\fs18\cf1\b0\i0\ul0\strike0 A\f1\fs18\cf1\b0\i0\ul0\strike0 recent\f1\fs18\cf1
\b0\i0\ul0\strike0 meta-analysis\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\u
l0\strike0 published\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\stri
ke0 the\f1\fs18\cf1\b0\i\ul0\strike0 Lancet\f1\fs18\cf1\b0\i0\ul0\strike0 ,\f1\f
s18\cf1\b0\i0\ul0\strike0 (9)\f1\fs18\cf1\b0\i0\ul0\strike0 intended\f1\fs18\cf1
\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 compare\par\pard\plain\li992
\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 impact\f
1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf
1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 primary\f1\fs18\cf1\b0\i0\u
l0\strike0 prevention\f1\fs18\cf1\b0\i0\ul0\strike0 versus\par\pard\plain\li992\
sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 secondary\f1\fs18\cf1\b0\i0\ul0\strike0 pre
vention,\f1\fs18\cf1\b0\i0\ul0\strike0 concluded\f1\fs18\cf1\b0\i0\ul0\strike0 t
hat\f1\fs18\cf1\b0\i0\ul0\strike0 the\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0
\i0\ul0\strike0 proportional\f1\fs18\cf1\b0\i0\ul0\strike0 reductions\f1\fs18\cf
1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 major\f1\fs18\cf1\b0\i0\ul0
\strike0 coronary\f1\fs18\cf1\b0\i0\ul0\strike0 events\par\pard\plain\li992\sl-2
27\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 ischemic\f1\f
s18\cf1\b0\i0\ul0\strike0 stroke\f1\fs18\cf1\b0\i0\ul0\strike0 was\f1\fs18\cf1\b
0\i0\ul0\strike0 similar\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\
strike0 both\f1\fs18\cf1\b0\i0\ul0\strike0 primary\par\pard\plain\li992\sl-227\f
1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 secondary\f1\fs18
\cf1\b0\i0\ul0\strike0 prevention\f1\fs18\cf1\b0\i0\ul0\strike0 trials,\f1\fs18\
cf1\b0\i0\ul0\strike0 yet\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul
0\strike0 reduction\f1\fs18\cf1\b0\i0\ul0\strike0 in\par\pard\plain\li992\sl-227
\f1\fs18\cf1\b0\i0\ul0\strike0 cardiovascular\f1\fs18\cf1\b0\i0\ul0\strike0 mort
ality\f1\fs18\cf1\b0\i0\ul0\strike0 was\f1\fs18\cf1\b0\i0\ul0\strike0 not\f1\fs1
8\cf1\b0\i0\ul0\strike0 significant\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1
\b0\i0\ul0\strike0 primary\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\str
ike0 prevention\f1\fs18\cf1\b0\i0\ul0\strike0 trials.\f1\fs18\cf1\b0\i0\ul0\stri
ke0 The\f1\fs18\cf1\b0\i0\ul0\strike0 US\f1\fs18\cf1\b0\i0\ul0\strike0 Preventiv
e\f1\fs18\cf1\b0\i0\ul0\strike0 Services\f1\fs18\cf1\b0\i0\ul0\strike0 Task\par\
pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 Force\f1\fs18\cf1\b0\i0\ul
0\strike0 (USPSTF)\f1\fs18\cf1\b0\i0\ul0\strike0 (10)\f1\fs18\cf1\b0\i0\ul0\stri
ke0 stands\f1\fs18\cf1\b0\i0\ul0\strike0 by\f1\fs18\cf1\b0\i0\ul0\strike0 its\f1
\fs18\cf1\b0\i0\ul0\strike0 seemingly\f1\fs18\cf1\b0\i0\ul0\strike0 broad\par\pa
rd\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 recommendations\f1\fs18\cf1\
b0\i0\ul0\strike0 for\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul
0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 prevent\f1\fs18\cf1\b0\i0\ul0\strike0
a\f1\fs18\cf1\b0\i0\ul0\strike0 first\f1\fs18\cf1\b0\i0\ul0\strike0 MI\f1\fs18\
cf1\b0\i0\ul0\strike0 in\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strik
e0 men\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 stroke\f1
\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 women.\f1\fs18\cf1\
b0\i0\ul0\strike0 However,\f1\fs18\cf1\b0\i0\ul0\strike0 a\f1\fs18\cf1\b0\i0\ul0
\strike0 steady\f1\fs18\cf1\b0\i0\ul0\strike0 stream\par\pard\plain\li992\sl-227
\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 studies\f1\fs18\
cf1\b0\i0\ul0\strike0 have\f1\fs18\cf1\b0\i0\ul0\strike0 warned\f1\fs18\cf1\b0\i
0\ul0\strike0 against\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul
0\strike0 use\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 som
e\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0
\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 key\f1\fs18\cf1\b0\i0\ul0\strike0

primary-prevention\f1\fs18\cf1\b0\i0\ul0\strike0 populations;\f1\fs18\cf1\b0\i0
\ul0\strike0 among\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 the
se,\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 meta-analysi
s\f1\fs18\cf1\b0\i0\ul0\strike0 published\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs
18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i\ul0\strike0 Lancet\f1\fs18\cf1\b0\
i0\ul0\strike0 (9)\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 fou
nd\f1\fs18\cf1\b0\i0\ul0\strike0 that\f1\fs18\cf1\b0\i0\ul0\strike0 while\f1\fs1
8\cf1\b0\i0\ul0\strike0 aspirin,\f1\fs18\cf1\b0\i0\ul0\strike0 used\f1\fs18\cf1\
b0\i0\ul0\strike0 for\f1\fs18\cf1\b0\i0\ul0\strike0 primary\f1\fs18\cf1\b0\i0\ul
0\strike0 prevention,\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0
may\f1\fs18\cf1\b0\i0\ul0\strike0 reduce\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs
18\cf1\b0\i0\ul0\strike0 risk\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0
\ul0\strike0 nonfatal\f1\fs18\cf1\b0\i0\ul0\strike0 ischemic\f1\fs18\cf1\b0\i0\u
l0\strike0 events,\f1\fs18\cf1\b0\i0\ul0\strike0 these\par\pard\plain\li992\sl-2
28\f1\fs18\cf1\b0\i0\ul0\strike0 benefits\f1\fs18\cf1\b0\i0\ul0\strike0 are\f1\f
s18\cf1\b0\i0\ul0\strike0 offset\f1\fs18\cf1\b0\i0\ul0\strike0 by\f1\fs18\cf1\b0
\i0\ul0\strike0 higher\f1\fs18\cf1\b0\i0\ul0\strike0 bleeding,\f1\fs18\cf1\b0\i0
\ul0\strike0 leaving\f1\fs18\cf1\b0\i0\ul0\strike0 no\f1\fs18\cf1\b0\i0\ul0\stri
ke0 net\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 effect\f1\fs18
\cf1\b0\i0\ul0\strike0 on\f1\fs18\cf1\b0\i0\ul0\strike0 vascular\f1\fs18\cf1\b0\
i0\ul0\strike0 mortality.\par\pard\plain\li1275\sl-227\f1\fs18\cf1\b0\i0\ul0\str
ike0 Evidence-based\f1\fs18\cf1\b0\i0\ul0\strike0 recommendations\f1\fs18\cf1\b0
\i0\ul0\strike0 (10-13)\f1\fs18\cf1\b0\i0\ul0\strike0 about\par\pard\plain\li992
\sl-239\f1\fs18\cf1\b0\i0\ul0\strike0 low-dose\f1\fs18\cf1\b0\i0\ul0\strike0 asp
irin\f1\fs18\cf1\b0\i0\ul0\strike0 therapy\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\f
s18\cf1\b0\i0\ul0\strike0 subjects\f1\fs18\cf1\b0\i0\ul0\strike0 with\f1\fs18\cf
1\b0\i0\ul0\strike0 CVR\f1\fs18\cf1\b0\i0\ul0\strike0 of\f2\fs18\cf1\b0\i0\ul0\s
trike0 \u8805?\f1\fs18\cf1\b0\i0\ul0\strike0 5%\par\pard\plain\li992\sl-216\f1\
fs18\cf1\b0\i0\ul0\strike0 at\f1\fs18\cf1\b0\i0\ul0\strike0 5\f1\fs18\cf1\b0\i0\
ul0\strike0 years\f1\fs18\cf1\b0\i0\ul0\strike0 or\f1\fs18\cf1\b0\i0\ul0\strike0
10%\f1\fs18\cf1\b0\i0\ul0\strike0 at\f1\fs18\cf1\b0\i0\ul0\strike0 10\f1\fs18\c
f1\b0\i0\ul0\strike0 years\f1\fs18\cf1\b0\i0\ul0\strike0 without\f1\fs18\cf1\b0\
i0\ul0\strike0 increased\f1\fs18\cf1\b0\i0\ul0\strike0 risk\par\pard\plain\li992
\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 bleeding\
f1\fs18\cf1\b0\i0\ul0\strike0 are\f1\fs18\cf1\b0\i0\ul0\strike0 still\f1\fs18\cf
1\b0\i0\ul0\strike0 valid\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0
\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 primary\f1\fs18\cf1\b0\i0\ul0\strike0
care\f1\fs18\cf1\b0\i0\ul0\strike0 level\f1\fs18\cf1\b0\i0\ul0\strike0 in\par\p
ard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 Argentina.\par\pard\plain\l
i1275\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 In\f1\fs18\cf1\b0\i0\ul0\strike0 2002
,\f1\fs18\cf1\b0\i0\ul0\strike0 The\f1\fs18\cf1\b0\i0\ul0\strike0 Ministry\f1\fs
18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 Health\f1\fs18\cf1\b0\
i0\ul0\strike0 implemented\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\str
ike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 Remediar\f1\fs18\cf1\b0\i0\ul0\strike0 Pr
ogram\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 supply\f1\f
s18\cf1\b0\i0\ul0\strike0 free\f1\fs18\cf1\b0\i0\ul0\strike0 essential\par\pard\
plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 medications,\f1\fs18\cf1\b0\i0\
ul0\strike0 including\f1\fs18\cf1\b0\i0\ul0\strike0 tablets\f1\fs18\cf1\b0\i0\ul
0\strike0 containing\f1\fs18\cf1\b0\i0\ul0\strike0 100\f1\fs18\cf1\b0\i0\ul0\str
ike0 mg\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1
\b0\i0\ul0\strike0 aspirin,\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\u
l0\strike0 people\f1\fs18\cf1\b0\i0\ul0\strike0 with\f1\fs18\cf1\b0\i0\ul0\strik
e0 lack\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 medical\f
1\fs18\cf1\b0\i0\ul0\strike0 coverage\par\pard\plain\li992\sl-228\f1\fs18\cf1\b0
\i0\ul0\strike0 directly\f1\fs18\cf1\b0\i0\ul0\strike0 from\f1\fs18\cf1\b0\i0\ul
0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 Primary\f1\fs18\cf1\b0\i0\ul0\strike
0 Health\f1\fs18\cf1\b0\i0\ul0\strike0 Care\f1\fs18\cf1\b0\i0\ul0\strike0 Center
s\par\pard\plain\li992\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 (PCCCs).\f1\fs18\cf1
\b0\i0\ul0\strike0 (14)\f1\fs18\cf1\b0\i0\ul0\strike0 The\f1\fs18\cf1\b0\i0\ul0\
strike0 Remediar\f1\fs18\cf1\b0\i0\ul0\strike0 Program\f1\fs18\cf1\b0\i0\ul0\str

ike0 was\f1\fs18\cf1\b0\i0\ul0\strike0 evaluated\par\pard\plain\li992\sl-228\f1\

fs18\cf1\b0\i0\ul0\strike0 by\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i
\ul0\strike0 Sistema\f1\fs18\cf1\b0\i\ul0\strike0 de\f1\fs18\cf1\b0\i\ul0\strike
0 Informaci\u243?n,\f1\fs18\cf1\b0\i\ul0\strike0 Monitoreo\f1\fs18\cf1\b0\i\ul0\
strike0 y\f1\fs18\cf1\b0\i\ul0\strike0 Evaluaci\u243?n\par\pard\plain\li992\sl-2
28\f1\fs18\cf1\b0\i\ul0\strike0 de\f1\fs18\cf1\b0\i\ul0\strike0 Programas\f1\fs1
8\cf1\b0\i0\ul0\strike0 (SIEMPRO,\f1\fs18\cf1\b0\i0\ul0\strike0 Program\f1\fs18\
cf1\b0\i0\ul0\strike0 Evaluation\f1\fs18\cf1\b0\i0\ul0\strike0 and\par\pard\colu
mn\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-20
0\par\pard\plain\sl-210\par\pard\plain\li4369\sl-185\f0\fs16\cf1\b\i0\ul0\strike
0 331\par\pard\plain\sl-346\par\pard\plain\li16\sl-229\f1\fs18\cf1\b0\i0\ul0\str
ike0 Monitoring\f1\fs18\cf1\b0\i0\ul0\strike0 System),\f1\fs18\cf1\b0\i0\ul0\str
ike0 which\f1\fs18\cf1\b0\i0\ul0\strike0 revealed\f1\fs18\cf1\b0\i0\ul0\strike0
that\f1\fs18\cf1\b0\i0\ul0\strike0 71%\f1\fs18\cf1\b0\i0\ul0\strike0 of\par\pard
\plain\li16\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 beneficiaries\f1\fs18\cf1\b0\i0
\ul0\strike0 were\f1\fs18\cf1\b0\i0\ul0\strike0 destitute,\f1\fs18\cf1\b0\i0\ul0
\strike0 20%\f1\fs18\cf1\b0\i0\ul0\strike0 were\f1\fs18\cf1\b0\i0\ul0\strike0 no
n-destitute\par\pard\plain\li16\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 poor\f1\fs1
8\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 84%\f1\fs18\cf1\b0\i0\
ul0\strike0 lacked\f1\fs18\cf1\b0\i0\ul0\strike0 medical\f1\fs18\cf1\b0\i0\ul0\s
trike0 coverage.\f1\fs18\cf1\b0\i0\ul0\strike0 (15)\f1\fs18\cf1\b0\i0\ul0\strike
0 In\f1\fs18\cf1\b0\i0\ul0\strike0 order\par\pard\plain\li16\sl-227\f1\fs18\cf1\
b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 obtain\f1\fs18\cf1\b0\i0\ul0\
strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 medications,\f1\fs18\cf1\b0\i0\ul0\str
ike0 patients\f1\fs18\cf1\b0\i0\ul0\strike0 had\f1\fs18\cf1\b0\i0\ul0\strike0 to
\f1\fs18\cf1\b0\i0\ul0\strike0 fill\f1\fs18\cf1\b0\i0\ul0\strike0 some\par\pard\
plain\li16\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 forms\f1\fs18\cf1\b0\i0\ul0\stri
ke0 regarding\f1\fs18\cf1\b0\i0\ul0\strike0 medical\f1\fs18\cf1\b0\i0\ul0\strike
0 diagnoses,\f1\fs18\cf1\b0\i0\ul0\strike0 prescriptions\f1\fs18\cf1\b0\i0\ul0\s
trike0 and\par\pard\plain\li16\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 demographic\
f1\fs18\cf1\b0\i0\ul0\strike0 data\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\
b0\i0\ul0\strike0 order\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\s
trike0 allow\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 con
struction\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 an\par\
pard\plain\li16\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 important\f1\fs18\cf1\b0\i0
\ul0\strike0 database.\par\pard\plain\li299\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0
The\f1\fs18\cf1\b0\i0\ul0\strike0 goal\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18
\cf1\b0\i0\ul0\strike0 this\f1\fs18\cf1\b0\i0\ul0\strike0 investigation\f1\fs18\
cf1\b0\i0\ul0\strike0 is\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\
strike0 analyze\f1\fs18\cf1\b0\i0\ul0\strike0 the\par\pard\plain\li16\sl-227\f1\
fs18\cf1\b0\i0\ul0\strike0 use\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i
0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\str
ike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 public\f1\fs18\cf1\b0\i0\ul0\strike0 prim
ary\f1\fs18\cf1\b0\i0\ul0\strike0 care\f1\fs18\cf1\b0\i0\ul0\strike0 level\f1\fs
18\cf1\b0\i0\ul0\strike0 (PCL)\par\pard\plain\li16\sl-228\f1\fs18\cf1\b0\i0\ul0\
strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 Argentina,\f1\fs18\cf1\b0\i0\ul0\strike
0 and\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 estimate\f1
\fs18\cf1\b0\i0\ul0\strike0 its\f1\fs18\cf1\b0\i0\ul0\strike0 effectiveness.\f1\
fs18\cf1\b0\i0\ul0\strike0 The\par\pard\plain\li16\sl-227\f1\fs18\cf1\b0\i0\ul0\
strike0 information\f1\fs18\cf1\b0\i0\ul0\strike0 available\f1\fs18\cf1\b0\i0\ul
0\strike0 allows\f1\fs18\cf1\b0\i0\ul0\strike0 exploring\f1\fs18\cf1\b0\i0\ul0\s
trike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 frequency\par\pard\plain\li16\sl-227\f1
\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 prescriptions\f1\fs
18\cf1\b0\i0\ul0\strike0 separated\f1\fs18\cf1\b0\i0\ul0\strike0 by\f1\fs18\cf1\
b0\i0\ul0\strike0 province\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\u
l0\strike0 beneficiaries,\par\pard\plain\li16\sl-228\f1\fs18\cf1\b0\i0\ul0\strik
e0 discussing\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 ad
herence\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 treatment
,\f1\fs18\cf1\b0\i0\ul0\strike0 generating\par\pard\plain\li16\sl-228\f1\fs18\cf
1\b0\i0\ul0\strike0 hypotheses\f1\fs18\cf1\b0\i0\ul0\strike0 about\f1\fs18\cf1\b

0\i0\ul0\strike0 limiting\f1\fs18\cf1\b0\i0\ul0\strike0 factors\f1\fs18\cf1\b0\i

0\ul0\strike0 against\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\st
rike0 best\par\pard\plain\li16\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 impact\f1\fs
18\cf1\b0\i0\ul0\strike0 on\f1\fs18\cf1\b0\i0\ul0\strike0 health\f1\fs18\cf1\b0\
i0\ul0\strike0 care,\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\str
ike0 quantifying\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0
costs\f1\fs18\cf1\b0\i0\ul0\strike0 of\par\pard\plain\li16\sl-227\f1\fs18\cf1\b
0\i0\ul0\strike0 treatment\f1\fs18\cf1\b0\i0\ul0\strike0 with\f1\fs18\cf1\b0\i0\
ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strike0 by\f1\fs18\cf1\b0\i0\ul0\strik
e0 person\f1\fs18\cf1\b0\i0\ul0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 effect
\f1\fs18\cf1\b0\i0\ul0\strike0 unit.\par\pard\plain\sl-200\par\pard\plain\sl-265
\par\pard\plain\li0\sl-188\f0\fs16\cf2\b0\i0\ul0\strike0 MATERIAL\f0\fs16\cf2\b0
\i0\ul0\strike0 AND\f0\fs16\cf2\b0\i0\ul0\strike0 METHODS\par\pard\plain\li4\s
l-358\f1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b0\i0\ul0\strike0 present\f1
\fs16\cf1\b0\i0\ul0\strike0 study\f1\fs16\cf1\b0\i0\ul0\strike0 about\f1\fs16\cf
1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 use\f1\fs16\cf1\b0\i0\ul0\
strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 medications\f1\fs16\cf1\b0\i0\ul0\strik
e0 has\f1\fs16\cf1\b0\i0\ul0\strike0 three\par\pard\plain\li4\sl-204\f1\fs16\cf1
\b0\i0\ul0\strike0 designs.\f1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b\i0\u
l0\strike0 first\f1\fs16\cf1\b\i0\ul0\strike0 design\f1\fs16\cf1\b0\i0\ul0\strik
e0 corresponds\f1\fs16\cf1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 an
\f1\fs16\cf1\b0\i0\ul0\strike0 ecological\par\pard\plain\li4\sl-203\f1\fs16\cf1\
b0\i0\ul0\strike0 or\f1\fs16\cf1\b0\i0\ul0\strike0 cluster\f1\fs16\cf1\b0\i0\ul0
\strike0 study\f1\fs16\cf1\b0\i0\ul0\strike0 \u8211?the\f1\fs16\cf1\b0\i0\ul0\st
rike0 unit\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 analys
is\f1\fs16\cf1\b0\i0\ul0\strike0 is\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf
1\b0\i0\ul0\strike0 country\f1\fs16\cf1\b0\i0\ul0\strike0 or\par\pard\plain\li4\
sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 regions,\f1\fs16\cf1\b0\i0\ul0\strike0 but\
f1\fs16\cf1\b0\i0\ul0\strike0 not\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\
b0\i0\ul0\strike0 persons.\f1\fs16\cf1\b0\i0\ul0\strike0 This\f1\fs16\cf1\b0\i0\
ul0\strike0 design\f1\fs16\cf1\b0\i0\ul0\strike0 studies\f1\fs16\cf1\b0\i0\ul0\s
trike0 populations\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 (clus
ters\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 prescription
s)\f1\fs16\cf1\b0\i0\ul0\strike0 without\f1\fs16\cf1\b0\i0\ul0\strike0 evaluatin
g\f1\fs16\cf1\b0\i0\ul0\strike0 patients\f1\fs16\cf1\b0\i0\ul0\strike0 or\par\pa
rd\plain\li4\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 clinical\f1\fs16\cf1\b0\i0\ul0
\strike0 histories,\f1\fs16\cf1\b0\i0\ul0\strike0 \u8211?\f1\fs16\cf1\b0\i0\ul0\
strike0 with\f1\fs16\cf1\b0\i0\ul0\strike0 cross\f1\fs16\cf1\b0\i0\ul0\strike0 c
omparisons\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 diagno
ses\f1\fs16\cf1\b0\i0\ul0\strike0 and\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i
0\ul0\strike0 prescriptions\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\u
l0\strike0 province\f1\fs16\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strik
e0 the\f1\fs16\cf1\b0\i0\ul0\strike0 public\f1\fs16\cf1\b0\i0\ul0\strike0 PCL\f1
\fs16\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strike0 Argentina.\par\pard
\plain\li4\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 (16)\f1\fs16\cf1\b0\i0\ul0\strik
e0 The\f1\fs16\cf1\b0\i0\ul0\strike0 secondary\f1\fs16\cf1\b0\i0\ul0\strike0 sou
rces\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 information\
f1\fs16\cf1\b0\i0\ul0\strike0 come\f1\fs16\cf1\b0\i0\ul0\strike0 from\f1\fs16\cf
1\b0\i0\ul0\strike0 the\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0
Remediar\f1\fs16\cf1\b0\i0\ul0\strike0 Program\f1\fs16\cf1\b0\i0\ul0\strike0 For
ms\f1\fs16\cf1\b0\i0\ul0\strike0 (Table\f1\fs16\cf1\b0\i0\ul0\strike0 1).\par\pa
rd\plain\li288\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b0\i0\ul0\st
rike0 units\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 analy
sis\f1\fs16\cf1\b0\i0\ul0\strike0 are\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\
cf1\b0\i0\ul0\strike0 fields\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\
ul0\strike0 the\f1\fs16\cf1\b\i0\ul0\strike0 R-Forms\par\pard\plain\li4\sl-204\f
1\fs16\cf1\b0\i0\ul0\strike0 or\f1\fs16\cf1\b\i0\ul0\strike0 prescriptions\f1\fs
16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0
\i0\ul0\strike0 made\f1\fs16\cf1\b0\i0\ul0\strike0 from\f1\fs16\cf1\b0\i0\ul0\st
rike0 March\f1\fs16\cf1\b0\i0\ul0\strike0 2005\f1\fs16\cf1\b0\i0\ul0\strike0 to\

par\pard\plain\li4\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 February\f1\fs16\cf1\b0\
i0\ul0\strike0 2006\f1\fs16\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strik
e0 almost\f1\fs16\cf1\b0\i0\ul0\strike0 6000\f1\fs16\cf1\b0\i0\ul0\strike0 PHCCs
\f1\fs16\cf1\b0\i0\ul0\strike0 nationwide.\f1\fs16\cf1\b0\i0\ul0\strike0 The\par
\pard\plain\li4\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 R-Form\f1\fs16\cf1\b0\i0\ul
0\strike0 allows\f1\fs16\cf1\b0\i0\ul0\strike0 delivery\f1\fs16\cf1\b0\i0\ul0\st
rike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 medicat
ion\f1\fs16\cf1\b0\i0\ul0\strike0 included\f1\fs16\cf1\b0\i0\ul0\strike0 in\f1\f
s16\cf1\b0\i0\ul0\strike0 the\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\st
rike0 Remediar\f1\fs16\cf1\b0\i0\ul0\strike0 kit\f1\fs16\cf1\b0\i0\ul0\strike0 t
o\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 patient,\f1\fs
16\cf1\b0\i0\ul0\strike0 which\f1\fs16\cf1\b0\i0\ul0\strike0 prescribed\f1\fs16\
cf1\b0\i0\ul0\strike0 during\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\str
ike0 medical\f1\fs16\cf1\b0\i0\ul0\strike0 consultation.\f1\fs16\cf1\b0\i0\ul0\s
trike0 All\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 p
rescriptions\f1\fs16\cf1\b0\i0\ul0\strike0 are\par\pard\plain\li4\sl-203\f1\fs16
\cf1\b0\i0\ul0\strike0 included.\f1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b
0\i0\ul0\strike0 diagnoses\f1\fs16\cf1\b0\i0\ul0\strike0 were\f1\fs16\cf1\b0\i0\
ul0\strike0 classified\f1\fs16\cf1\b0\i0\ul0\strike0 using\f1\fs16\cf1\b0\i0\ul0
\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 Coding\par\pard\plain\li4\sl-204\f1\f
s16\cf1\b0\i0\ul0\strike0 Manual\f1\fs16\cf1\b0\i0\ul0\strike0 CEPS-AP,\f1\fs16\
cf1\b0\i0\ul0\strike0 first\f1\fs16\cf1\b0\i0\ul0\strike0 edition,\f1\fs16\cf1\b
0\i0\ul0\strike0 which\f1\fs16\cf1\b0\i0\ul0\strike0 was\f1\fs16\cf1\b0\i0\ul0\s
trike0 in\f1\fs16\cf1\b0\i0\ul0\strike0 force\f1\fs16\cf1\b0\i0\ul0\strike0 when
\f1\fs16\cf1\b0\i0\ul0\strike0 the\par\pard\plain\li4\sl-203\f1\fs16\cf1\b0\i0\u
l0\strike0 prescriptions\f1\fs16\cf1\b0\i0\ul0\strike0 were\f1\fs16\cf1\b0\i0\ul
0\strike0 made.\f1\fs16\cf1\b0\i0\ul0\strike0 (17)\f1\fs16\cf1\b0\i0\ul0\strike0
The\f1\fs16\cf1\b0\i0\ul0\strike0 beneficiaries\f1\fs16\cf1\b0\i0\ul0\strike0 w
ere\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 unequivocally\f1\fs1
6\cf1\b0\i0\ul0\strike0 individualized\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\
cf1\b0\i0\ul0\strike0 means\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\u
l0\strike0 a\f1\fs16\cf1\b0\i0\ul0\strike0 verification\par\pard\plain\li4\sl-20
4\f1\fs16\cf1\b0\i0\ul0\strike0 procedure\f1\fs16\cf1\b0\i0\ul0\strike0 implemen
ted\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\c
f1\b0\i\ul0\strike0 Sistema\f1\fs16\cf1\b0\i\ul0\strike0 de\f1\fs16\cf1\b0\i\ul0
\strike0 Identificaci\u243?n\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i\ul0\stri
ke0 Nacional\f1\fs16\cf1\b0\i\ul0\strike0 Tributario\f1\fs16\cf1\b0\i\ul0\strike
0 y\f1\fs16\cf1\b0\i\ul0\strike0 Social\f1\fs16\cf1\b0\i0\ul0\strike0 (SINTyS,\f
1\fs16\cf1\b0\i0\ul0\strike0 National\f1\fs16\cf1\b0\i0\ul0\strike0 System\f1\fs
16\cf1\b0\i0\ul0\strike0 for\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\str
ike0 Social\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 Tax\
f1\fs16\cf1\b0\i0\ul0\strike0 Identification).\par\pard\plain\li288\sl-203\f1\fs
16\cf1\b0\i0\ul0\strike0 Each\f1\fs16\cf1\b0\i0\ul0\strike0 month,\f1\fs16\cf1\b
0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 PHCC\f1\fs16\cf1\b0\i0\ul0\st
rike0 provides\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 R
emediar\f1\fs16\cf1\b0\i0\ul0\strike0 Program\par\pard\plain\li4\sl-204\f1\fs16\
cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\strike0 a\f1\fs16\cf1\b\i0\ul0\
strike0 B-Form\f1\fs16\cf1\b0\i0\ul0\strike0 that\f1\fs16\cf1\b0\i0\ul0\strike0
has\f1\fs16\cf1\b0\i0\ul0\strike0 information\f1\fs16\cf1\b0\i0\ul0\strike0 cons
olidated\f1\fs16\cf1\b0\i0\ul0\strike0 about\par\pard\plain\li4\sl-204\f1\fs16\c
f1\b0\i0\ul0\strike0 pharmaceuticals\u8217?\f1\fs16\cf1\b0\i0\ul0\strike0 consum
ption\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 medical\f1
\fs16\cf1\b0\i0\ul0\strike0 consultations.\par\pard\plain\li288\sl-204\f1\fs16\c
f1\b0\i0\ul0\strike0 Data\f1\fs16\cf1\b0\i0\ul0\strike0 from\f1\fs16\cf1\b0\i0\u
l0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 number\f1\fs16\cf1\b0\i0\ul0\strike
0 of\f1\fs16\cf1\b0\i0\ul0\strike0 beneficiaries\f1\fs16\cf1\b0\i0\ul0\strike0 o
f\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 Remediar\par\p
ard\plain\li4\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 Program\f1\fs16\cf1\b0\i0\ul0
\strike0 were\f1\fs16\cf1\b0\i0\ul0\strike0 crossed\f1\fs16\cf1\b0\i0\ul0\strike
0 with\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 projected

\f1\fs16\cf1\b0\i0\ul0\strike0 target\f1\fs16\cf1\b0\i0\ul0\strike0 population\p

ar\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\
strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 First\f1\fs16\cf1\b0\i0\ul0\strike0 Na
tional\f1\fs16\cf1\b0\i0\ul0\strike0 Survey\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\
fs16\cf1\b0\i0\ul0\strike0 Risk\f1\fs16\cf1\b0\i0\ul0\strike0 Factors\f1\fs16\cf
1\b0\i0\ul0\strike0 (NSRF).\f1\fs16\cf1\b0\i0\ul0\strike0 (18)\par\pard\plain\li
4\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 Similar\f1\fs16\cf1\b0\i0\ul0\strike0 to\
f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 ATP\f1\fs16\cf1\
b0\i0\ul0\strike0 III\f1\fs16\cf1\b0\i0\ul0\strike0 (19)\f1\fs16\cf1\b0\i0\ul0\s
trike0 ,\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 NSRF\f1
\fs16\cf1\b0\i0\ul0\strike0 allows\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1
\b0\i0\ul0\strike0 possibility\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\s
trike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 classifying\f1\fs16\cf1\b0\i0\ul0\strike
0 the\f1\fs16\cf1\b0\i0\ul0\strike0 Argentine\f1\fs16\cf1\b0\i0\ul0\strike0 popu
lation\f1\fs16\cf1\b0\i0\ul0\strike0 exclusively\f1\fs16\cf1\b0\i0\ul0\strike0 u
nder\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 public\f1\fs16\cf1\
b0\i0\ul0\strike0 medical\f1\fs16\cf1\b0\i0\ul0\strike0 coverage,\f1\fs16\cf1\b0
\i0\ul0\strike0 according\f1\fs16\cf1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0
\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 number\f1\fs16\cf1\b0\i0\ul0\strike0
of\f1\fs16\cf1\b0\i0\ul0\strike0 risk\par\pard\plain\li4\sl-203\f1\fs16\cf1\b0\i
0\ul0\strike0 factors,\f1\fs16\cf1\b0\i0\ul0\strike0 in:\f1\fs16\cf1\b0\i0\ul0\s
trike0 low\f1\fs16\cf1\b0\i0\ul0\strike0 CVR\f1\fs16\cf1\b0\i0\ul0\strike0 (0\f1
\fs16\cf1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 1\f1\fs16\cf1\b0\i0
\ul0\strike0 RF;\f1\fs16\cf1\b0\i0\ul0\strike0 <\f1\fs16\cf1\b0\i0\ul0\strike0 1
0%\f1\fs16\cf1\b0\i0\ul0\strike0 risk\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\c
f1\b0\i0\ul0\strike0 events\f1\fs16\cf1\b0\i0\ul0\strike0 at\f1\fs16\cf1\b0\i0\u
l0\strike0 10\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 years);\f1
\fs16\cf1\b0\i0\ul0\strike0 moderate\f1\fs16\cf1\b0\i0\ul0\strike0 CVR\f1\fs16\c
f1\b0\i0\ul0\strike0 (2\f1\fs16\cf1\b0\i0\ul0\strike0 RF;\f1\fs16\cf1\b0\i0\ul0\
strike0 10-20%);\f1\fs16\cf1\b0\i0\ul0\strike0 high\f1\fs16\cf1\b0\i0\ul0\strike
0 CVR\f1\fs16\cf1\b0\i0\ul0\strike0 (=\f1\fs16\cf1\b0\i0\ul0\strike0 or\f1\fs16\
cf1\b0\i0\ul0\strike0 more\par\pard\plain\li4\sl-204\f1\fs16\cf1\b0\i0\ul0\strik
e0 3;\f1\fs16\cf1\b0\i0\ul0\strike0 >\f1\fs16\cf1\b0\i0\ul0\strike0 20%).\par\pa
rd\plain\li299\sl-362\f1\fs16\cf1\b0\i0\ul0\strike0 Coverage\f1\fs16\cf1\b0\i0\u
l0\strike0 was\f1\fs16\cf1\b0\i0\ul0\strike0 calculated\f1\fs16\cf1\b0\i0\ul0\st
rike0 as\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 ratio\f
1\fs16\cf1\b0\i0\ul0\strike0 between:\par\pard\plain\li813\sl-391\f1\fs16\cf1\b0
\i0\ul0\strike0 Cases\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\str
ike0 beneficiaries\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\stri
ke0 aspirin\par\pard\plain\li1154\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 prescript
ions\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 province\par
\pard\plain\li4129\sl-175\f0\fs16\cf1\b0\i0\ul0\strike0 \u215?\f1\fs16\cf1\b0\i0
\ul0\strike0 100\par\pard\plain\li625\sl-316\f1\fs16\cf1\b0\i0\ul0\strike0 Cases
\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\strike0 CVR\f1\fs16\cf
1\b0\i0\ul0\strike0 >10%\f1\fs16\cf1\b0\i0\ul0\strike0 exclusively\f1\fs16\cf1\b
0\i0\ul0\strike0 under\par\pard\plain\li319\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0
public\f1\fs16\cf1\b0\i0\ul0\strike0 medical\f1\fs16\cf1\b0\i0\ul0\strike0 cove
rage\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 province\f1\
fs16\cf1\b0\i0\ul0\strike0 according\f1\fs16\cf1\b0\i0\ul0\strike0 to\par\pard\p
lain\li1663\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strik
e0 NSRF.
{\shp{\*\shpinst\shpleft10517\shptop1205\shpright987\shpbottom1205
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz1\shplid2385
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}

{\sp{\sn lineColor}{\sv 3476658}}

{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft5885\shptop14018\shpright9964\shpbottom14018
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz158\shplid2385
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 2105123}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}\sect\sectd\sbkpage\pgwsxn11338\pghsxn15874\sected\cols2\colno1\colw5310\colsr
10\colno2\colw6000\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200
\par\pard\plain\sl-200\par\pard\plain\sl-210\par\pard\plain\li822\sl-185\f0\fs16
\cf1\b\i0\ul0\strike0 332\par\pard\column\plain\sl-200\par\pard\plain\sl-200\par
\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-228\par\pard\plain\li
0\sl-171\f1\fs14\cf1\b0\i0\ul0\strike0 REVISTA\f1\fs14\cf1\b0\i0\ul0\strike0 ARG
ENTINA\f1\fs14\cf1\b0\i0\ul0\strike0 DE\f1\fs14\cf1\b0\i0\ul0\strike0 CARDIOLOG\
u205?A\f1\fs14\cf1\b0\i0\ul0\strike0 /\f0\fs14\cf1\b0\i0\ul0\strike0 VOL\f0\fs1
4\cf1\b0\i0\ul0\strike0 78\f0\fs14\cf1\b0\i0\ul0\strike0 N\u186?\f0\fs14\cf1\b
0\i0\ul0\strike0 4\f1\fs14\cf1\b0\i0\ul0\strike0 /\f0\fs14\cf1\b0\i0\ul0\strike
0 JULY-AUGUST\f0\fs14\cf1\b0\i0\ul0\strike0 2010\par\sect\sected\sbknone\cols1
\colno1\colw11320\pard\plain\sl-200\par\pard\plain\sl-229\par\pard\plain\li822\s
l-185\f0\fs16\cf2\b\i0\ul0\strike0 Table\f0\fs16\cf2\b\i0\ul0\strike0 1\f0\fs16
\cf1\b0\i0\ul0\strike0 Methodology\f0\fs16\cf1\b0\i0\ul0\strike0 used\f0\fs16\
cf1\b0\i0\ul0\strike0 for\f0\fs16\cf1\b0\i0\ul0\strike0 the\f0\fs16\cf1\b0\i0\
ul0\strike0 analysis\f0\fs16\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i0\ul0\st
rike0 the\f0\fs16\cf1\b0\i0\ul0\strike0 information\par\sect\sected\sbknone\co
ls4\colno1\colw3390\colsr10\colno2\colw2430\colsr10\colno3\colw2430\colsr10\coln
o4\colw3040\pard\plain\sl-200\par\pard\plain\li963\sl-192\f0\fs16\cf3\b0\i0\ul0\
strike0 Source\par\pard\plain\li963\sl-330\f0\fs16\cf1\b0\i0\ul0\strike0 R\f0\fs
16\cf1\b0\i0\ul0\strike0 Form\par\pard\plain\li963\sl-191\f0\fs16\cf1\b0\i0\ul0
\strike0 (Remediar\f0\fs16\cf1\b0\i0\ul0\strike0 Prescription)\par\pard\column\
plain\sl-200\par\pard\plain\li0\sl-192\f0\fs16\cf3\b0\i0\ul0\strike0 Content\par
\pard\plain\li0\sl-330\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul
0\strike0 Diagnosis\f0\fs16\cf1\b0\i0\ul0\strike0 code\par\pard\plain\li0\sl-2
48\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0\strike0 Treatment
\f0\fs16\cf1\b0\i0\ul0\strike0 prescribe\par\pard\plain\li0\sl-192\f0\fs16\cf1\
b0\i0\ul0\strike0 Patient\u8217?s\f0\fs16\cf1\b0\i0\ul0\strike0 basic\f0\fs16\c
f1\b0\i0\ul0\strike0 data\f0\fs16\cf1\b0\i0\ul0\strike0 (age,\par\pard\plain\l
i0\sl-191\f0\fs16\cf1\b0\i0\ul0\strike0 gender,\f0\fs16\cf1\b0\i0\ul0\strike0 e
tc.)\par\pard\column\plain\sl-200\par\pard\plain\li0\sl-191\f0\fs16\cf3\b0\i0\ul
0\strike0 Unit\f0\fs16\cf3\b0\i0\ul0\strike0 of\f0\fs16\cf3\b0\i0\ul0\strike0
analysis\par\pard\plain\li0\sl-330\f0\fs16\cf1\b0\i0\ul0\strike0 Universe\f0\fs1
6\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i0\ul0\strike0 15\f0\fs16\cf1\b0\i0\
ul0\strike0 million\par\pard\plain\li0\sl-191\f0\fs16\cf1\b0\i0\ul0\strike0 pre
scription\f0\fs16\cf1\b0\i0\ul0\strike0 from\f0\fs16\cf1\b0\i0\ul0\strike0 Feb

ruary\par\pard\plain\li0\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 2005\f0\fs16\cf1\b
0\i0\ul0\strike0 to\f0\fs16\cf1\b0\i0\ul0\strike0 March\f0\fs16\cf1\b0\i0\ul0\
strike0 2006\par\pard\column\plain\sl-200\par\pard\plain\li0\sl-191\f0\fs16\cf3
\b0\i0\ul0\strike0 Main\f0\fs16\cf3\b0\i0\ul0\strike0 indicators\par\pard\plain
\li0\sl-330\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0\strike0
Frequency\f0\fs16\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i\ul0\strike0 diagno
sis\par\pard\plain\li0\sl-191\f0\fs16\cf1\b0\i0\ul0\strike0 (prescriptions\f0\fs
16\cf1\b0\i0\ul0\strike0 with\f0\fs16\cf1\b0\i0\ul0\strike0 diagnosis\par\pard
\plain\li0\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i0\ul0\strike0
diabetes/total\par\pard\plain\li0\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 prescri
ptions)\par\sect\sected\sbknone\cols1\colno1\colw11320\pard\plain\li8299\sl-192\
f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0\strike0 Frequency\f0
\fs16\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i\ul0\strike0 treatments\par\par
d\plain\li8299\sl-191\f0\fs16\cf1\b0\i\ul0\strike0 prescribed\f0\fs16\cf1\b0\i\u
l0\strike0 per\f0\fs16\cf1\b0\i\ul0\strike0 diagnosis\par\pard\plain\li8299\sl
-248\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0\strike0 Frequen
cy\f0\fs16\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i\ul0\strike0 treatments\pa
r\pard\plain\li8299\sl-191\f0\fs16\cf1\b0\i\ul0\strike0 prescribed\f0\fs16\cf1\b
0\i\ul0\strike0 per\f0\fs16\cf1\b0\i\ul0\strike0 beneficiary\par\sect\sected\s
bknone\cols4\colno1\colw3390\colsr10\colno2\colw2430\colsr10\colno3\colw2430\col
sr10\colno4\colw3040\pard\plain\li963\sl-356\f0\fs16\cf1\b0\i0\ul0\strike0 Cross
over\f0\fs16\cf1\b0\i0\ul0\strike0 information\f0\fs16\cf1\b0\i0\ul0\strike0 o
f\par\pard\plain\li963\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 R-Form\f0\fs16\cf1\b
0\i0\ul0\strike0 and\f0\fs16\cf1\b0\i0\ul0\strike0 SINTyS\f0\fs16\cf1\b0\i0\ul
0\strike0 database\par\pard\plain\li0\sl-356\column\f0\fs16\cf1\b0\i0\ul0\strik
e0 Identification\f0\fs16\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i0\ul0\strike
0 Remediar\par\pard\plain\li0\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 beneficiarie
s\par\pard\plain\li0\sl-356\column\f0\fs16\cf1\b0\i0\ul0\strike0 Population\f0\f
s16\cf1\b0\i0\ul0\strike0 who\f0\fs16\cf1\b0\i0\ul0\strike0 received\par\pard\
plain\li0\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 Remediar\f0\fs16\cf1\b0\i0\ul0\st
rike0 medication\par\pard\plain\li0\sl-356\column\f0\fs16\cf1\b0\i0\ul0\strike0
\u183?\f0\fs16\cf1\b0\i0\ul0\strike0 Number\f0\fs16\cf1\b0\i0\ul0\strike0 of\
f0\fs16\cf1\b0\i0\ul0\strike0 beneficiaries\par\pard\plain\li0\sl-192\f0\fs16\c
f1\b0\i0\ul0\strike0 identified\f0\fs16\cf1\b0\i0\ul0\strike0 by\f0\fs16\cf1\b0
\i0\ul0\strike0 group,\f0\fs16\cf1\b0\i0\ul0\strike0 age,\par\sect\sected\sbkn
one\cols1\colno1\colw11320\pard\plain\li8299\sl-192\f0\fs16\cf1\b0\i0\ul0\strike
0 province,\f0\fs16\cf1\b0\i0\ul0\strike0 etc.\par\sect\sected\sbknone\cols4\co
lno1\colw3390\colsr10\colno2\colw2430\colsr10\colno3\colw2430\colsr10\colno4\col
w3040\pard\plain\sl-210\par\pard\plain\li963\sl-180\f0\fs16\cf1\b0\i0\ul0\strike
0 B-Form\par\pard\plain\li963\sl-191\f0\fs16\cf1\b0\i0\ul0\strike0 (Monthly\f0\f
s16\cf1\b0\i0\ul0\strike0 Medication\f0\fs16\cf1\b0\i0\ul0\strike0 Con-\par\pa
rd\plain\li963\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 sumption\f0\fs16\cf1\b0\i0\u
l0\strike0 and\f0\fs16\cf1\b0\i0\ul0\strike0 Consultation\par\pard\plain\li963
\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 Records)\par\pard\column\plain\sl-210\par\
pard\plain\li0\sl-180\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0
\strike0 Consumption\f0\fs16\cf1\b0\i0\ul0\strike0 per\par\pard\plain\li0\sl-1
91\f0\fs16\cf1\b0\i0\ul0\strike0 medication\par\pard\plain\li0\sl-248\f0\fs16\cf
1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i\ul0\strike0 Stock\f0\fs16\cf1\b0\i0
\ul0\strike0 or\f0\fs16\cf1\b0\i0\ul0\strike0 availability\f0\fs16\cf1\b0\i0\u
l0\strike0 per\par\pard\plain\li0\sl-191\f0\fs16\cf1\b0\i0\ul0\strike0 medicati
on\f0\fs16\cf1\b0\i0\ul0\strike0 (in\f0\fs16\cf1\b0\i0\ul0\strike0 moths)\par\
pard\plain\li0\sl-248\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0
\strike0 Consultations\f0\fs16\cf1\b0\i0\ul0\strike0 (total)\par\pard\plain\li
0\sl-248\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0\strike0 Rem
ediar\f0\fs16\cf1\b0\i0\ul0\strike0 prescriptions\par\pard\column\plain\sl-210\
par\pard\plain\li0\sl-180\f0\fs16\cf1\b0\i0\ul0\strike0 Total\f0\fs16\cf1\b0\i0\
ul0\strike0 Forms\f0\fs16\cf1\b0\i0\ul0\strike0 submitted\f0\fs16\cf1\b0\i0\ul
0\strike0 by\par\pard\plain\li0\sl-191\f0\fs16\cf1\b0\i0\ul0\strike0 PHCC,\f0\f
s16\cf1\b0\i0\ul0\strike0 consolidated\f0\fs16\cf1\b0\i0\ul0\strike0 to\par\pa
rd\plain\li0\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 present\par\pard\column\plain\

sl-209\par\pard\plain\li0\sl-181\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf
1\b0\i\ul0\strike0 Medication\f0\fs16\cf1\b0\i\ul0\strike0 prescription\par\pa
rd\plain\li0\sl-191\f0\fs16\cf1\b0\i\ul0\strike0 rate\f0\fs16\cf1\b0\i0\ul0\stri
ke0 per\f0\fs16\cf1\b0\i0\ul0\strike0 100\f0\fs16\cf1\b0\i0\ul0\strike0 consu
ltations\par\pard\plain\li0\sl-248\f0\fs16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\
cf1\b0\i\ul0\strike0 Availability\f0\fs16\cf1\b0\i0\ul0\strike0 (months\f0\fs1
6\cf1\b0\i0\ul0\strike0 of\par\pard\plain\li0\sl-191\f0\fs16\cf1\b0\i0\ul0\stri
ke0 average\f0\fs16\cf1\b0\i0\ul0\strike0 use\f0\fs16\cf1\b0\i0\ul0\strike0 co
vered\f0\fs16\cf1\b0\i0\ul0\strike0 by\f0\fs16\cf1\b0\i0\ul0\strike0 the\par\p
ard\plain\li0\sl-192\f0\fs16\cf1\b0\i0\ul0\strike0 the\f0\fs16\cf1\b0\i0\ul0\str
ike0 stocks\f0\fs16\cf1\b0\i0\ul0\strike0 of\f0\fs16\cf1\b0\i0\ul0\strike0 me
dicine\f0\fs16\cf1\b0\i0\ul0\strike0 left\par\pard\plain\li0\sl-192\f0\fs16\cf1
\b0\i0\ul0\strike0 at\f0\fs16\cf1\b0\i0\ul0\strike0 the\f0\fs16\cf1\b0\i0\ul0\s
trike0 each\f0\fs16\cf1\b0\i0\ul0\strike0 PHCC)\par\pard\plain\li0\sl-248\f0\f
s16\cf1\b0\i0\ul0\strike0 \u183?\f0\fs16\cf1\b0\i0\ul0\strike0 Average\f0\fs16\
cf1\b0\i0\ul0\strike0 consultations\f0\fs16\cf1\b0\i0\ul0\strike0 and\par\sect
\sected\sbknone\cols1\colno1\colw11320\pard\plain\li8299\sl-192\f0\fs16\cf1\b0\i
0\ul0\strike0 prescriptions\f0\fs16\cf1\b0\i0\ul0\strike0 per\f0\fs16\cf1\b0\i0
\ul0\strike0 month\par\pard\plain\li8299\sl-248\f0\fs16\cf1\b0\i0\ul0\strike0 \
u183?\f0\fs16\cf1\b0\i0\ul0\strike0 Remediar\f0\fs16\cf1\b0\i0\ul0\strike0 pre
scription\f0\fs16\cf1\b0\i0\ul0\strike0 rate\par\pard\plain\li8299\sl-191\f0\fs
16\cf1\b0\i0\ul0\strike0 per\f0\fs16\cf1\b0\i0\ul0\strike0 consultations\par\se
ct\sected\sbknone\cols2\colno1\colw5690\colsr10\colno2\colw5620\pard\plain\sl-32
8\par\pard\plain\li1105\sl-205\f1\fs16\cf1\b0\i0\ul0\strike0 Effective\f1\fs16\c
f1\b0\i0\ul0\strike0 treatment\f1\fs16\cf1\b0\i0\ul0\strike0 was\f1\fs16\cf1\b0\
i0\ul0\strike0 defined\f1\fs16\cf1\b0\i0\ul0\strike0 as\f1\fs16\cf1\b0\i0\ul0\st
rike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 monthly\f1\fs16\cf1\b0\i0\ul0\strike0 de
livery\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\
b0\i0\ul0\strike0 30\f1\fs16\cf1\b0\i0\ul0\strike0 doses\f1\fs16\cf1\b0\i0\ul0\s
trike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 pe
r\f1\fs16\cf1\b0\i0\ul0\strike0 patient,\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs
16\cf1\b0\i0\ul0\strike0 treatment\f1\fs16\cf1\b0\i0\ul0\strike0 persistence\par
\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 compliance\f1\fs16\cf1\b0
\i0\ul0\strike0 was\f1\fs16\cf1\b0\i0\ul0\strike0 evaluated\f1\fs16\cf1\b0\i0\ul
0\strike0 analyzing\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\stri
ke0 number\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 months
\par\pard\plain\li822\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 per\f1\fs16\cf1\b0\i0
\ul0\strike0 year\f1\fs16\cf1\b0\i0\ul0\strike0 that\f1\fs16\cf1\b0\i0\ul0\strik
e0 each\f1\fs16\cf1\b0\i0\ul0\strike0 patient\f1\fs16\cf1\b0\i0\ul0\strike0 requ
ired\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 treatment\f
1\fs16\cf1\b0\i0\ul0\strike0 during\f1\fs16\cf1\b0\i0\ul0\strike0 1\par\pard\pla
in\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 year.\par\pard\plain\li1105\sl-203
\f1\fs16\cf1\b0\i0\ul0\strike0 Availability\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\
fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 was\f1\fs16\cf1
\b0\i0\ul0\strike0 analyzed\f1\fs16\cf1\b0\i0\ul0\strike0 at\f1\fs16\cf1\b0\i0\u
l0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 beginning\f1\fs16\cf1\b0\i0\ul0\str
ike0 of\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf
1\b0\i0\ul0\strike0 studied\f1\fs16\cf1\b0\i0\ul0\strike0 period\f1\fs16\cf1\b0\
i0\ul0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 defined\f1\fs16\cf1\b0\i0\ul0\s
trike0 as\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 months
\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 use\f1\fs16\cf1\
b0\i0\ul0\strike0 covered\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\stri
ke0 by\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 stocks\f1
\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 medicine\f1\fs16\cf
1\b0\i0\ul0\strike0 left\f1\fs16\cf1\b0\i0\ul0\strike0 at\f1\fs16\cf1\b0\i0\ul0\
strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 each\f1\fs16\cf1\b0\i0\ul0\strike0 cen
ter\f1\fs16\cf1\b0\i0\ul0\strike0 if\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\c
f1\b0\i0\ul0\strike0 rate\f1\fs16\cf1\b0\i0\ul0\strike0 of\par\pard\plain\li822\
sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 use\f1\fs16\cf1\b0\i0\ul0\strike0 did\f1\fs
16\cf1\b0\i0\ul0\strike0 not\f1\fs16\cf1\b0\i0\ul0\strike0 vary.\par\pard\plain\

li1105\sl-204\f1\fs16\charscalex93\cf1\b0\i0\ul0\strike0 The\f1\fs16\charscalex9
3\cf1\b\i0\ul0\strike0 second\f1\fs16\charscalex93\cf1\b\i0\ul0\strike0 design\f
1\fs16\charscalex93\cf1\b0\i0\ul0\strike0 is\f1\fs16\charscalex93\cf1\b0\i0\ul0\
strike0 an\f1\fs16\charscalex93\cf1\b0\i0\ul0\strike0 evaluation\f1\fs16\charsca
lex93\cf1\b0\i0\ul0\strike0 of\f1\fs16\charscalex93\cf1\b0\i0\ul0\strike0 the\f1
\fs16\charscalex90\cf1\b\i0\ul0\strike0 counterfactual\par\pard\plain\li822\sl-2
04\f1\fs16\charscalex90\cf1\b\i0\ul0\strike0 approach\f1\fs16\cf1\b0\i0\ul0\stri
ke0 of\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 impact\f1
\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 proper\f1\fs16\cf1
\b0\i0\ul0\strike0 use\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\st
rike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 might\f1\fs16\cf1\b0\i0\ul0\strike0
have\par\pard\plain\li822\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 for\f1\fs16\cf1\b
0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 prevention\f1\fs16\cf1\b0\i0\
ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 CVD.\f1\fs16\cf1\b0\i0\ul0\strike0
This\f1\fs16\cf1\b0\i0\ul0\strike0 design\f1\fs16\cf1\b0\i0\ul0\strike0 is\f1\fs
16\cf1\b0\i0\ul0\strike0 used\f1\fs16\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0
\ul0\strike0 health\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 as
sessment\f1\fs16\cf1\b0\i0\ul0\strike0 when\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1
\fs16\cf1\b0\i0\ul0\strike0 results\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1
\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 interventions\f1\fs16\cf1\b
0\i0\ul0\strike0 cannot\par\pard\plain\li822\sl-203\f1\fs16\cf1\b0\i0\ul0\strike
0 be\f1\fs16\cf1\b0\i0\ul0\strike0 compared\f1\fs16\cf1\b0\i0\ul0\strike0 with\f
1\fs16\cf1\b0\i0\ul0\strike0 control\f1\fs16\cf1\b0\i0\ul0\strike0 groups.\f1\fs
16\cf1\b0\i0\ul0\strike0 A\f1\fs16\cf1\b0\i0\ul0\strike0 counterfactual\f1\fs16\
cf1\b0\i0\ul0\strike0 event\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\st
rike0 is\f1\fs16\cf1\b0\i0\ul0\strike0 a\f1\fs16\cf1\b0\i0\ul0\strike0 consequen
ce\f1\fs16\cf1\b0\i0\ul0\strike0 or\f1\fs16\cf1\b0\i0\ul0\strike0 condition\f1\f
s16\cf1\b0\i0\ul0\strike0 that\f1\fs16\cf1\b0\i0\ul0\strike0 cannot\f1\fs16\cf1\
b0\i0\ul0\strike0 be\f1\fs16\cf1\b0\i0\ul0\strike0 observed\f1\fs16\cf1\b0\i0\ul
0\strike0 by\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 human\f1\
fs16\cf1\b0\i0\ul0\strike0 investigation\f1\fs16\cf1\b0\i0\ul0\strike0 but\f1\fs
16\cf1\b0\i0\ul0\strike0 could\f1\fs16\cf1\b0\i0\ul0\strike0 have\f1\fs16\cf1\b0
\i0\ul0\strike0 happened.\par\pard\plain\li1105\sl-203\f1\fs16\cf1\b0\i0\ul0\str
ike0 The\f1\fs16\cf1\b0\i0\ul0\strike0 PICO\f1\fs16\cf1\b0\i0\ul0\strike0 method
\f1\fs16\cf1\b0\i0\ul0\strike0 is\f1\fs16\cf1\b0\i0\ul0\strike0 useful\f1\fs16\c
f1\b0\i0\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 build\f1\fs16\cf1\b0\i0\ul
0\strike0 clinical\f1\fs16\cf1\b0\i0\ul0\strike0 questions\par\pard\plain\li822\
sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 (20):\f1\fs16\cf1\b0\i0\ul0\strike0 Patient
\f1\fs16\cf1\b0\i0\ul0\strike0 or\f1\fs16\cf1\b0\i0\ul0\strike0 Population,\f1\f
s16\cf1\b0\i0\ul0\strike0 Intervention,\f1\fs16\cf1\b0\i0\ul0\strike0 Comparison
\f1\fs16\cf1\b0\i0\ul0\strike0 and\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0
\ul0\strike0 Outcome.\par\pard\plain\li1105\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0
The\f1\fs16\cf1\b0\i0\ul0\strike0 impact\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs
16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 use\f1\fs16\cf1\b0\i0
\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\stri
ke0 is\f1\fs16\cf1\b0\i0\ul0\strike0 based\f1\fs16\cf1\b0\i0\ul0\strike0 on\f1\f
s16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 evidence\par\pard\pl
ain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 showing\f1\fs16\cf1\b0\i0\ul0\str
ike0 that\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 re
duces\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 risk\f1\fs
16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 CVD\f1\fs16\cf1\b0\i0\
ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 25%.\f1\fs16\cf1\b0\i0\ul0\strike0
(21)\par\pard\plain\li822\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 However,\f1\fs16\
cf1\b0\i0\ul0\strike0 for\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul
0\strike0 purposes\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike
0 this\f1\fs16\cf1\b0\i0\ul0\strike0 analysis,\f1\fs16\cf1\b0\i0\ul0\strike0 we\
f1\fs16\cf1\b0\i0\ul0\strike0 considered\par\pard\plain\li822\sl-204\f1\fs16\cf1
\b0\i0\ul0\strike0 that\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\
strike0 potential\f1\fs16\cf1\b0\i0\ul0\strike0 impact\f1\fs16\cf1\b0\i0\ul0\str
ike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 prov

ided\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 the\par\pard

\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 Remediar\f1\fs16\cf1\b0\i0\ul0
\strike0 Program\f1\fs16\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strike0
the\f1\fs16\cf1\b0\i0\ul0\strike0 target\f1\fs16\cf1\b0\i0\ul0\strike0 populatio
n\f1\fs16\cf1\b0\i0\ul0\strike0 was\f1\fs16\cf1\b0\i0\ul0\strike0 a\f1\fs16\cf1\
b0\i0\ul0\strike0 reduction\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\st
rike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 CVD\f1\fs16\cf1\b0\i0\ul0\strike0 risk\f1
\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 12%\f1\fs16\cf1\b0\
i0\ul0\strike0 (RR\f1\fs16\cf1\b0\i0\ul0\strike0 =\f1\fs16\cf1\b0\i0\ul0\strike0
0.88,\f1\fs16\cf1\b0\i0\ul0\strike0 0.82\f1\fs16\cf1\b0\i0\ul0\strike0 -\f1\fs1
6\cf1\b0\i0\ul0\strike0 0.94),\f1\fs16\cf1\b0\i0\ul0\strike0 a\f1\fs16\cf1\b0\i0
\ul0\strike0 conservative\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\stri
ke0 approach\f1\fs16\cf1\b0\i0\ul0\strike0 based\f1\fs16\cf1\b0\i0\ul0\strike0 o
n\f1\fs16\cf1\b0\i0\ul0\strike0 findings\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs1
6\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 most\f1\fs16\cf1\b0\i0
\ul0\strike0 recent\f1\fs16\cf1\b0\i0\ul0\strike0 meta\f1\fs16\cf1\b0\i0\ul0\str
ike0 analyses.\par\pard\plain\li822\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 (9)\f1\
fs16\cf1\b0\i0\ul0\strike0 Three\f1\fs16\cf1\b0\i0\ul0\strike0 possible\f1\fs16\
cf1\b0\i0\ul0\strike0 scenarios\f1\fs16\cf1\b0\i0\ul0\strike0 were\f1\fs16\cf1\b
0\i0\ul0\strike0 considered\f1\fs16\cf1\b0\i0\ul0\strike0 depending\f1\fs16\cf1\
b0\i0\ul0\strike0 on\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 t
he\f1\fs16\cf1\b0\i0\ul0\strike0 population\f1\fs16\cf1\b0\i0\ul0\strike0 consid
ered.\f1\fs16\cf1\b0\i0\ul0\strike0 A\f1\fs16\cf1\b0\i0\ul0\strike0 minimal\f1\f
s16\cf1\b0\i0\ul0\strike0 risk\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i
0\ul0\strike0 events\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\stri
ke0 10%\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf
1\b0\i0\ul0\strike0 a\f1\fs16\cf1\b0\i0\ul0\strike0 maximal\f1\fs16\cf1\b0\i0\ul
0\strike0 risk\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 20
%\f1\fs16\cf1\b0\i0\ul0\strike0 were\f1\fs16\cf1\b0\i0\ul0\strike0 considered\f1
\fs16\cf1\b0\i0\ul0\strike0 at\f1\fs16\cf1\b0\i0\ul0\strike0 10\f1\fs16\cf1\b0\i
0\ul0\strike0 years.\par\pard\plain\li822\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 \
u8211?\f1\fs16\cf1\b0\i0\ul0\strike0 Population:\f1\fs16\cf1\b0\i0\ul0\strike0 s
ubjects\f1\fs16\cf1\b0\i0\ul0\strike0 >\f1\fs16\cf1\b0\i0\ul0\strike0 50\f1\fs16
\cf1\b0\i0\ul0\strike0 years\f1\fs16\cf1\b0\i0\ul0\strike0 (an\f1\fs16\cf1\b0\i0
\ul0\strike0 arbitrary\f1\fs16\cf1\b0\i0\ul0\strike0 cut-off\par\pard\plain\li11
05\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 value,\f1\fs16\cf1\b0\i0\ul0\strike0 bet
ween\f1\fs16\cf1\b0\i0\ul0\strike0 45\f1\fs16\cf1\b0\i0\ul0\strike0 years\f1\fs1
6\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strike0 men\f1\fs16\cf1\b0\i0\u
l0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 55\f1\fs16\cf1\b0\i0\ul0\strike0 ye
ars\f1\fs16\cf1\b0\i0\ul0\strike0 in\f1\fs16\cf1\b0\i0\ul0\strike0 women,\par\pa
rd\plain\li1105\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 according\f1\fs16\cf1\b0\i0
\ul0\strike0 to\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0
Framingham\f1\fs16\cf1\b0\i0\ul0\strike0 study),\f1\fs16\cf1\b0\i0\ul0\strike0 h
igh\f1\fs16\cf1\b0\i0\ul0\strike0 CVR\f1\fs16\cf1\b0\i0\ul0\strike0 and\par\pard
\plain\li1105\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 exclusive\f1\fs16\cf1\b0\i0\u
l0\strike0 public\f1\fs16\cf1\b0\i0\ul0\strike0 medical\f1\fs16\cf1\b0\i0\ul0\st
rike0 coverage:\f1\fs16\cf1\b0\i\ul0\strike0 Scenario\f1\fs16\cf1\b0\i\ul0\strik
e0 1\f1\fs16\cf1\b0\i0\ul0\strike0 .\par\pard\plain\li1105\sl-204\f1\fs16\cf1\b0
\i0\ul0\strike0 Beneficiaries\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0
\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 Remediar\f1\fs16\cf1\b0\i0\ul0\st
rike0 Program\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\strike0 p
rescriptions\par\pard\plain\li1105\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs
16\cf1\b0\i0\ul0\strike0 aspirin:\f1\fs16\cf1\b0\i\ul0\strike0 Scenario\f1\fs16\
cf1\b0\i\ul0\strike0 2\f1\fs16\cf1\b0\i0\ul0\strike0 .\f1\fs16\cf1\b0\i0\ul0\str
ike0 Beneficiaries\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike
0 the\f1\fs16\cf1\b0\i0\ul0\strike0 Remediar\par\pard\plain\li1105\sl-204\f1\fs1
6\cf1\b0\i0\ul0\strike0 Program\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b
0\i0\ul0\strike0 high\f1\fs16\cf1\b0\i0\ul0\strike0 CVR\f1\fs16\cf1\b0\i0\ul0\st
rike0 (with\f1\fs16\cf1\b0\i0\ul0\strike0 HT\f1\fs16\cf1\b0\i0\ul0\strike0 and/o
r\f1\fs16\cf1\b0\i0\ul0\strike0 diabetes)\f1\fs16\cf1\b0\i0\ul0\strike0 with\par

\pard\plain\li1105\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 or\f1\fs16\cf1\b0\i0\ul0
\strike0 without\f1\fs16\cf1\b0\i0\ul0\strike0 prescription\f1\fs16\cf1\b0\i0\ul
0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin:\f1\fs16\cf1\b0\i\ul0\strike0
Scenario\f1\fs16\cf1\b0\i\ul0\strike0 3\f1\fs16\cf1\b0\i0\ul0\strike0 .\f1\fs16
\cf1\b0\i0\ul0\strike0 Population\par\pard\plain\li1105\sl-204\f1\fs16\cf1\b0\i0
\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\strike0 high\f1\fs16\cf1\b0\i0\ul0\strik
e0 CVR,\f1\fs16\cf1\b0\i0\ul0\strike0 according\f1\fs16\cf1\b0\i0\ul0\strike0 to
\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 NRFS.\par\pard\
column\plain\sl-328\par\pard\plain\li0\sl-205\f1\fs16\cf1\b0\i0\ul0\strike0 \u82
11?\f1\fs16\cf1\b0\i0\ul0\strike0 Intervention:\f1\fs16\cf1\b0\i0\ul0\strike0 pr
escription\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0\i0\ul0\strike0 daily
\f1\fs16\cf1\b0\i0\ul0\strike0 use\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\
b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 in\par\pard\plain\li283\
sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 populatio
ns\f1\fs16\cf1\b0\i0\ul0\strike0 described.\par\pard\plain\li0\sl-204\f1\fs16\cf
1\b0\i0\ul0\strike0 \u8211?\f1\fs16\cf1\b0\i0\ul0\strike0 Comparison:\f1\fs16\cf
1\b0\i0\ul0\strike0 the\f1\fs16\cf1\b0\i0\ul0\strike0 same\f1\fs16\cf1\b0\i0\ul0
\strike0 populations\f1\fs16\cf1\b0\i0\ul0\strike0 that\f1\fs16\cf1\b0\i0\ul0\st
rike0 were\f1\fs16\cf1\b0\i0\ul0\strike0 not\f1\fs16\cf1\b0\i0\ul0\strike0 using
\par\pard\plain\li283\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 aspirin\f1\fs16\cf1\b
0\i0\ul0\strike0 or\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0\ul0\str
ike0 insufficient\f1\fs16\cf1\b0\i0\ul0\strike0 medication.\par\pard\plain\li0\s
l-204\f1\fs16\cf1\b0\i0\ul0\strike0 \u8211?\f1\fs16\cf1\b0\i0\ul0\strike0 Outcom
e\f1\fs16\cf1\b0\i0\ul0\strike0 or\f1\fs16\cf1\b0\i0\ul0\strike0 impact:\f1\fs16
\cf1\b0\i0\ul0\strike0 number\f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0
\ul0\strike0 events\f1\fs16\cf1\b0\i0\ul0\strike0 prevented.\par\pard\plain\li28
3\sl-204\f1\fs16\cf1\b0\i0\ul0\strike0 The\f1\fs16\cf1\b\i0\ul0\strike0 third\f1
\fs16\cf1\b\i0\ul0\strike0 design\f1\fs16\cf1\b0\i0\ul0\strike0 is\f1\fs16\cf1\b
0\i0\ul0\strike0 a\f1\fs16\cf1\b\i0\ul0\strike0 calculation\f1\fs16\cf1\b\i0\ul0
\strike0 of\f1\fs16\cf1\b\i0\ul0\strike0 medication\f1\fs16\cf1\b\i0\ul0\strike0
costs\par\pard\plain\li0\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0
\i0\ul0\strike0 beneficiary\f1\fs16\cf1\b0\i0\ul0\strike0 with\f1\fs16\cf1\b0\i0
\ul0\strike0 high\f1\fs16\cf1\b0\i0\ul0\strike0 CVR\f1\fs16\cf1\b0\i0\ul0\strike
0 and\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0 event\f1\fs
16\cf1\b0\i0\ul0\strike0 prevented\par\pard\plain\li0\sl-204\f1\fs16\cf1\b0\i0\u
l0\strike0 (effect\f1\fs16\cf1\b0\i0\ul0\strike0 unit)\f1\fs16\cf1\b0\i0\ul0\str
ike0 after\f1\fs16\cf1\b0\i0\ul0\strike0 10\f1\fs16\cf1\b0\i0\ul0\strike0 years\
f1\fs16\cf1\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 therapy.\f1\fs16\
cf1\b0\i0\ul0\strike0 Costs\f1\fs16\cf1\b0\i0\ul0\strike0 were\f1\fs16\cf1\b0\i0
\ul0\strike0 calculated\par\pard\plain\li0\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0
in\f1\fs16\cf1\b0\i0\ul0\strike0 United\f1\fs16\cf1\b0\i0\ul0\strike0 States\f1\
fs16\cf1\b0\i0\ul0\strike0 Dollars\f1\fs16\cf1\b0\i0\ul0\strike0 (USD)\f1\fs16\c
f1\b0\i0\ul0\strike0 according\f1\fs16\cf1\b0\i0\ul0\strike0 to:\f1\fs16\cf1\b0\
i0\ul0\strike0 1)\f1\fs16\cf1\b0\i0\ul0\strike0 Remediar\par\pard\plain\li0\sl-2
04\f1\fs16\cf1\b0\i0\ul0\strike0 Program\f1\fs16\cf1\b0\i0\ul0\strike0 purchase\
f1\fs16\cf1\b0\i0\ul0\strike0 price\f1\fs16\cf1\b0\i0\ul0\strike0 plus\f1\fs16\c
f1\b0\i0\ul0\strike0 management\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0
\i0\ul0\strike0 distribution\par\pard\plain\li0\sl-203\f1\fs16\cf1\b0\i0\ul0\str
ike0 costs.\f1\fs16\cf1\b0\i0\ul0\strike0 (22)\f1\fs16\cf1\b0\i0\ul0\strike0 2)\
f1\fs16\cf1\b0\i0\ul0\strike0 Aspirin\f1\fs16\cf1\b0\i0\ul0\strike0 retail\f1\fs
16\cf1\b0\i0\ul0\strike0 price.\f1\fs16\cf1\b0\i0\ul0\strike0 (23)\f1\fs16\cf1\b
0\i0\ul0\strike0 The\f1\fs16\cf1\b0\i0\ul0\strike0 costs\f1\fs16\cf1\b0\i0\ul0\s
trike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 medical\par\pard\plain\li0\sl-204\f1\fs1
6\cf1\b0\i0\ul0\strike0 visits\f1\fs16\cf1\b0\i0\ul0\strike0 and\f1\fs16\cf1\b0\
i0\ul0\strike0 laboratory\f1\fs16\cf1\b0\i0\ul0\strike0 tests\f1\fs16\cf1\b0\i0\
ul0\strike0 were\f1\fs16\cf1\b0\i0\ul0\strike0 not\f1\fs16\cf1\b0\i0\ul0\strike0
considered.\f1\fs16\cf1\b0\i0\ul0\strike0 The\par\pard\plain\li0\sl-204\f1\fs16
\cf1\b0\i0\ul0\strike0 economic\f1\fs16\cf1\b0\i0\ul0\strike0 impact\f1\fs16\cf1
\b0\i0\ul0\strike0 of\f1\fs16\cf1\b0\i0\ul0\strike0 treatment\f1\fs16\cf1\b0\i0\
ul0\strike0 costs\f1\fs16\cf1\b0\i0\ul0\strike0 by\f1\fs16\cf1\b0\i0\ul0\strike0

beneficiary\f1\fs16\cf1\b0\i0\ul0\strike0 on\f1\fs16\cf1\b0\i0\ul0\strike0 mean

\par\pard\plain\li0\sl-203\f1\fs16\cf1\b0\i0\ul0\strike0 households\u8217?\f1\fs
16\cf1\b0\i0\ul0\strike0 income\f1\fs16\cf1\b0\i0\ul0\strike0 is\f1\fs16\cf1\b0\
i0\ul0\strike0 evaluated.\par\pard\plain\sl-200\par\pard\plain\sl-261\par\pard\p
lain\li0\sl-188\f0\fs16\cf2\b0\i0\ul0\strike0 RESULTS\par\pard\plain\li0\sl-379\
f1\fs18\cf1\b0\i0\ul0\strike0 From\f1\fs18\cf1\b0\i0\ul0\strike0 a\f1\fs18\cf1\b
0\i0\ul0\strike0 total\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\st
rike0 15,001,041\f1\fs18\cf1\b0\i0\ul0\strike0 prescriptions\f1\fs18\cf1\b0\i0\u
l0\strike0 recorded\par\pard\plain\li0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 duri
ng\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 year\f1\fs18\
cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0
\strike0 study,\f1\fs18\cf1\b0\i0\ul0\strike0 225,411\f1\fs18\cf1\b0\i0\ul0\stri
ke0 corresponded\f1\fs18\cf1\b0\i0\ul0\strike0 to\par\pard\plain\li0\sl-227\f1\f
s18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strike0 prescriptions,\f
1\fs18\cf1\b0\i0\ul0\strike0 frequency\f1\fs18\cf1\b0\i0\ul0\strike0 1.5%.\f1\fs
18\cf1\b0\i0\ul0\strike0 Among\f1\fs18\cf1\b0\i0\ul0\strike0 96,755\par\pard\pla
in\li0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 prescriptions\f1\fs18\cf1\b0\i0\ul0\
strike0 in\f1\fs18\cf1\b0\i0\ul0\strike0 patients\f1\fs18\cf1\b0\i0\ul0\strike0
>\f1\fs18\cf1\b0\i0\ul0\strike0 50\f1\fs18\cf1\b0\i0\ul0\strike0 years\f1\fs18\c
f1\b0\i0\ul0\strike0 with\f1\fs18\cf1\b0\i0\ul0\strike0 high\f1\fs18\cf1\b0\i0\u
l0\strike0 CVR,\f1\fs18\cf1\b0\i0\ul0\strike0 60\par\pard\plain\li0\sl-228\f1\fs
18\cf1\b0\i0\ul0\strike0 408\f1\fs18\cf1\b0\i0\ul0\strike0 beneficiaries\f1\fs18
\cf1\b0\i0\ul0\strike0 were\f1\fs18\cf1\b0\i0\ul0\strike0 identified.\f1\fs18\cf
1\b0\i0\ul0\strike0 Figure\f1\fs18\cf1\b0\i0\ul0\strike0 1\f1\fs18\cf1\b0\i0\ul0
\strike0 shows\f1\fs18\cf1\b0\i0\ul0\strike0 the\par\pard\plain\li0\sl-227\f1\fs
18\cf1\b0\i0\ul0\strike0 distribution\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\c
f1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1\b0\i0\ul0\strike0 use\f1\fs18\cf1\b0\i0
\ul0\strike0 by\f1\fs18\cf1\b0\i0\ul0\strike0 age.\f1\fs18\cf1\b0\i0\ul0\strike0
In\f1\fs18\cf1\b0\i0\ul0\strike0 patients\f1\fs18\cf1\b0\i0\ul0\strike0 <\f1\fs
18\cf1\b0\i0\ul0\strike0 16\f1\fs18\cf1\b0\i0\ul0\strike0 years\par\pard\plain\l
i0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 (12.8%\f1\fs18\cf1\b0\i0\ul0\strike0 of\
f1\fs18\cf1\b0\i0\ul0\strike0 prescriptions)\f1\fs18\cf1\b0\i0\ul0\strike0 the\f
1\fs18\cf1\b0\i0\ul0\strike0 most\f1\fs18\cf1\b0\i0\ul0\strike0 frequent\f1\fs18
\cf1\b0\i0\ul0\strike0 diagnoses\par\pard\plain\li0\sl-228\f1\fs18\cf1\b0\i0\ul0
\strike0 were\f1\fs18\cf1\b0\i0\ul0\strike0 pharyngitis,\f1\fs18\cf1\b0\i0\ul0\s
trike0 fever,\f1\fs18\cf1\b0\i0\ul0\strike0 cold\f1\fs18\cf1\b0\i0\ul0\strike0 a
nd\f1\fs18\cf1\b0\i0\ul0\strike0 pain.\f1\fs18\cf1\b0\i0\ul0\strike0 In\f1\fs18\
cf1\b0\i0\ul0\strike0 subjects\f1\fs18\cf1\b0\i0\ul0\strike0 <\par\pard\plain\li
0\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 50\f1\fs18\cf1\b0\i0\ul0\strike0 years\f1
\fs18\cf1\b0\i0\ul0\strike0 (64.5%\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\
b0\i0\ul0\strike0 prescriptions),\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\
b0\i0\ul0\strike0 diagnoses\f1\fs18\cf1\b0\i0\ul0\strike0 were\par\pard\plain\li
0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 hypertension\f1\fs18\cf1\b0\i0\ul0\strike
0 (60.1%),\f1\fs18\cf1\b0\i0\ul0\strike0 other\f1\fs18\cf1\b0\i0\ul0\strike0 car
diovascular\f1\fs18\cf1\b0\i0\ul0\strike0 diseases\par\pard\plain\li0\sl-227\f1\
fs18\cf1\b0\i0\ul0\strike0 (8%),\f1\fs18\cf1\b0\i0\ul0\strike0 diabetes\f1\fs18\
cf1\b0\i0\ul0\strike0 (7.4%),\f1\fs18\cf1\b0\i0\ul0\strike0 pain\f1\fs18\cf1\b0\
i0\ul0\strike0 (6.5%),\f1\fs18\cf1\b0\i0\ul0\strike0 heart\f1\fs18\cf1\b0\i0\ul0
\strike0 failure\par\pard\plain\li0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 (5.8%),
\f1\fs18\cf1\b0\i0\ul0\strike0 ischemic\f1\fs18\cf1\b0\i0\ul0\strike0 heart\f1\f
s18\cf1\b0\i0\ul0\strike0 disease\f1\fs18\cf1\b0\i0\ul0\strike0 (4.5%),\f1\fs18\
cf1\b0\i0\ul0\strike0 cerebrovascular\par\pard\plain\li0\sl-227\f1\fs18\cf1\b0\i
0\ul0\strike0 disease\f1\fs18\cf1\b0\i0\ul0\strike0 (0.4%),\f1\fs18\cf1\b0\i0\ul
0\strike0 and\f1\fs18\cf1\b0\i0\ul0\strike0 other\f1\fs18\cf1\b0\i0\ul0\strike0
diagnoses\f1\fs18\cf1\b0\i0\ul0\strike0 (26.7%).\f1\fs18\cf1\b0\i0\ul0\strike0 A
mong\par\pard\plain\li0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 aspirin\f1\fs18\cf1
\b0\i0\ul0\strike0 prescriptions,\f1\fs18\cf1\b0\i0\ul0\strike0 61.22%\f1\fs18\c
f1\b0\i0\ul0\strike0 corresponded\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18\cf1\b
0\i0\ul0\strike0 women\par\pard\plain\li0\sl-228\f1\fs18\cf1\b0\i0\ul0\strike0 a
nd\f1\fs18\cf1\b0\i0\ul0\strike0 38.78%\f1\fs18\cf1\b0\i0\ul0\strike0 to\f1\fs18

\cf1\b0\i0\ul0\strike0 men;\f1\fs18\cf1\b0\i0\ul0\strike0 this\f1\fs18\cf1\b0\i0

\ul0\strike0 distribution\f1\fs18\cf1\b0\i0\ul0\strike0 was\f1\fs18\cf1\b0\i0\ul
0\strike0 similar\f1\fs18\cf1\b0\i0\ul0\strike0 to\par\pard\plain\li0\sl-227\f1\
fs18\cf1\b0\i0\ul0\strike0 that\f1\fs18\cf1\b0\i0\ul0\strike0 of\f1\fs18\cf1\b0\
i0\ul0\strike0 general\f1\fs18\cf1\b0\i0\ul0\strike0 medical\f1\fs18\cf1\b0\i0\u
l0\strike0 consultations\f1\fs18\cf1\b0\i0\ul0\strike0 in\f1\fs18\cf1\b0\i0\ul0\
strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 PCL.\par\pard\plain\li283\sl-228\f1\fs
18\cf1\b0\i0\ul0\strike0 Aspirin\f1\fs18\cf1\b0\i0\ul0\strike0 was\f1\fs18\cf1\b
0\i0\ul0\strike0 prescribed\f1\fs18\cf1\b0\i0\ul0\strike0 due\f1\fs18\cf1\b0\i0\
ul0\strike0 to\f1\fs18\cf1\b0\i0\ul0\strike0 the\f1\fs18\cf1\b0\i0\ul0\strike0 f
ollowing\par\pard\plain\li0\sl-227\f1\fs18\cf1\b0\i0\ul0\strike0 conditions:\f1\
fs18\cf1\b0\i0\ul0\strike0 HT\f1\fs18\cf1\b0\i0\ul0\strike0 (7.1%),\f1\fs18\cf1\
b0\i0\ul0\strike0 type\f1\fs18\cf1\b0\i0\ul0\strike0 2\f1\fs18\cf1\b0\i0\ul0\str
ike0 diabetes\f1\fs18\cf1\b0\i0\ul0\strike0 (2.9%),\f1\fs18\cf1\b0\i0\ul0\strike
0 heart
{\shp{\*\shpinst\shpleft10346\shptop1205\shpright817\shpbottom1205
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz1\shplid2412
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 3476658}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft10332\shptop1559\shpright822\shpbottom1559
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz8\shplid2412
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 3476658}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft10332\shptop1872\shpright822\shpbottom1872
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz9\shplid2412
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 3476658}}
{\sp{\sn lineWidth}{\sv 12700}}

{\sp{\sn lineDashing}{\sv 0}}

{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft822\shptop1940\shpright10352\shpbottom2294
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz12\shplid1340
{\sp{\sn shapeType}{\sv 0}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn geoRight}{\sv 9530}}
{\sp{\sn geoBottom}{\sv 354}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn pVerticies}{\sv 8;5;(0,354);(9530,354);(9530,0);(0,0);(0,354)}}
{\sp{\sn pSegmentInfo}{\sv 2;12;16384;45824;1;45824;1;45824;1;45824;1;45824;2457
7;32768}}
{\sp{\sn fFillOK}{\sv 1}}
{\sp{\sn fFilled}{\sv 1}}
{\sp{\sn fillColor}{\sv 3476658}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn fLine}{\sv 0}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft822\shptop2298\shpright10352\shpbottom7087
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz13\shplid1340
{\sp{\sn shapeType}{\sv 0}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn geoRight}{\sv 9530}}
{\sp{\sn geoBottom}{\sv 4789}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn pVerticies}{\sv 8;5;(0,4788);(9530,4788);(9530,0);(0,0);(0,4788)}}
{\sp{\sn pSegmentInfo}{\sv 2;12;16384;45824;1;45824;1;45824;1;45824;1;45824;2457
7;32768}}
{\sp{\sn fFillOK}{\sv 1}}
{\sp{\sn fFilled}{\sv 1}}
{\sp{\sn fillColor}{\sv 12698095}}
{\sp{\sn lineWidth}{\sv 12700}}
{\sp{\sn fLine}{\sv 0}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft765\shptop4087\shpright10394\shpbottom4087
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz110\shplid2412
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}

{\sp{\sn shapePath}{\sv 4}}

{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 16777215}}
{\sp{\sn lineWidth}{\sv 25400}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}
{\shp{\*\shpinst\shpleft765\shptop4862\shpright10394\shpbottom4862
\shpfhdr0\shpbxpage\shpbypage
\shpwr3\shpwrk0\shpfblwtxt1\shpz111\shplid2412
{\sp{\sn shapeType}{\sv 20}}
{\sp{\sn fFlipH}{\sv 0}}
{\sp{\sn fFlipV}{\sv 0}}
{\sp{\sn shapePath}{\sv 4}}
{\sp{\sn fFillOK}{\sv 0}}
{\sp{\sn fLayoutInCell}{\sv 1}}
{\sp{\sn lineColor}{\sv 16777215}}
{\sp{\sn lineWidth}{\sv 25400}}
{\sp{\sn lineDashing}{\sv 0}}
{\sp{\sn posrelh}{\sv 1}}
{\sp{\sn posrelv}{\sv 1}}
{\sp{\sn fArrowheadsOK}{\sv 1}}
{\sp{\sn fBehindDocument}{\sv 1}}
}}\sect\sectd\sbkpage\pgwsxn11338\pghsxn15874\sected\cols1\colno1\colw11320\pard
\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-399\
par\pard\plain\li954\sl-366\f3\fs30\cf4\b\i0\ul0\strike0 Thank you for evaluatin
g AnyBizSoft PDF to Word.\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\p
lain\sl-200\par\pard\plain\sl-233\par\pard\plain\li3435\sl-274\f3\fs22\cf4\b\i0\
ul0\strike0 You can only convert 3 pages with the trial version.\par\pard\plain\
sl-200\par\pard\plain\sl-200\par\pard\plain\sl-200\par\pard\plain\sl-325\par\par
d\plain\li1908\sl-274\f3\fs22\cf4\b\i0\ul0\strike0 To get all the pages converte
d, you need to purchase the software from:\par\pard\plain\sl-200\par\pard\plain\
sl-200\par\pard\plain\sl-200\par\pard\plain\sl-325\par\pard\plain\li3435\sl-229{
\field{\*\fldinst {\hich\af0\dbch\af17\loch\f0 HYPERLINK "http://www.anypdftools
.com/buy/buy-pdf-to-word.html"}}{\fldrslt {\cs15\ul\cf2 \hich\af0\dbch\af17\loch
\f3\fs18\cf5\b0\i\ul\strike0 http://www.anypdftools.com/buy/buy-pdf-to-word.html
}}}}